<i>ackA</i><br/>
E, S<br/>
Fluoroacetate resistance<br/>
96, 281, 463, 797<br/>
L<br/>
<i>ada</i><br/>
E<br/>
Nitrosoguanidine resistance<br/>
693<br/>
<i>add</i><br/>
E<br/>
Deoxyadenosine + hypoxanthine satisfaction of <i>purB</i> requirement<br/>
370<br/>
L<br/>
<i>add</i><br/>
S<br/>
Deoxyadenosine (low) satisfaction of <i>purA</i> requirement<br/>
326<br/>
L<br/>
<i>adhCE</i><br/>
E<br/>
Chloracetaldehyde resistance<br/>
157<br/>
<i>adhCE</i><br/>
E<br/>
Chlorethanol resistance<br/>
157<br/>
<i>adhE</i><br/>
E<br/>
Allyl alcohol resistance<br/>
476<br/>
L<br/>
<i>adh</i><br/>
E<br/>
Ethanol as C source<br/>
132<br/>
C<br/>
<i>alaS</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
394<br/>
S<br/>
<i>alaS</i><br/>
E<br/>
Mecillinam resistance (beta-lactam resistance)<br/>
802<br/>
S<br/>
<i>ampC</i><br/>
E<br/>
Ampicillin resistance<br/>
139, 570<br/>
D<br/>
<i>ampC</i><br/>
E<br/>
Ampicillin resistance<br/>
210, 212, 362<br/>
C<br/>
<i>amtAB</i><br/>
S<br/>
Aminotriazole resistance<br/>
828<br/>
<i>apeA</i><br/>
E, S<br/>
<i>N</i>-Acetyl-L-phenylalanine-β-naphthyl ester hydrolysis<br/>
421, 516<br/>
L<br/>
<i>apt</i><br/>
E<br/>
6-Methylpurine resistance<br/>
60<br/>
L<br/>
<i>apt</i><br/>
E<br/>
Adenine resistance in <i>hpt gpt</i><br/>
462<br/>
<i>apt</i><br/>
E<br/>
2,6-Diaminopurine resistance in <i>pnp</i><br/>
470<br/>
L<br/>
<i>apt</i><br/>
E, S<br/>
2,6-Diaminopurine resistance<br/>
107, 390<br/>
L<br/>
<i>araB</i><br/>
E<br/>
Ribitol resistance from <i>araC</i>(Con)<br/>
396<br/>
L<br/>
<i>araC</i><br/>
E<br/>
Fucose resistance (arabinose as C source)<br/>
67<br/>
C<br/>
<i>araC</i><br/>
E<br/>
Ribitol resistance from <i>araC</i>(Con)<br/>
396<br/>
L<br/>
<i>arcA</i><br/>
E<br/>
Male-specific phage resistance, also called <i>fexA</i><br/>
110, 651, 711<br/>
L<br/>
<i>argA</i><br/>
E<br/>
Acetylornithine + uracil satisfaction of <i>car</i> (<i>pyrA</i>)<br/>
153<br/>
L<br/>
<i>argB</i><br/>
E<br/>
<i>N</i>-Acetylhistidine + ornithine satisfaction of <i>his</i><br/>
50<br/>
C<br/>
<i>argB</i><br/>
E<br/>
Acetylornithine + uracil satisfaction of <i>car</i> (<i>pyrA</i>)<br/>
153<br/>
L<br/>
<i>argC</i><br/>
E<br/>
<i>N</i>-Acetylhistidine + ornithine satisfaction of <i>his</i><br/>
50<br/>
C<br/>
<i>argC</i><br/>
E<br/>
Acetylornithine + uracil satisfaction of <i>car</i> (<i>pyrA</i>)<br/>
153<br/>
L<br/>
<i>argD</i><br/>
E, S<br/>
Proline-independent growth of ∆<i>proAB</i><br/>
62, 403<br/>
L<br/>
<i>argD</i><br/>
E<br/>
Acetylornithine + uracil satisfaction of <i>car</i> (<i>pyrA</i>)<br/>
153<br/>
L<br/>
<i>argE</i><br/>
E<br/>
<i>N</i>-Acetylhistidine + ornithine satisfaction of <i>his</i><br/>
50<br/>
C<br/>
<i>argE</i><br/>
E<br/>
Acetylnorvaline resistance in <i>argR</i>(Con)<br/>
402<br/>
L<br/>
<i>argH</i><br/>
E<br/>
<i>N</i>-Acetylhistidine + ornithine satisfaction of <i>his</i><br/>
50<br/>
C<br/>
<i>argP</i><br/>
E<br/>
Canavanine resistance<br/>
483, 655<br/>
L<br/>
<i>argP</i><br/>
E<br/>
Thiosine resistance<br/>
293, 716<br/>
L<br/>
<i>argP</i><br/>
E<br/>
Canavanine + thiouracil resistance<br/>
605<br/>
L<br/>
<i>argR</i><br/>
E, S<br/>
Arginine-resistant, proline-independent growth of ∆<i>pro</i><br/>
62, 403<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Acetylhistidine satisfaction of <i>his</i><br/>
49, 50, 403<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Acetylmethionine satisfaction of <i>met</i><br/>
402<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Indospicine resistance<br/>
454<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Canavanine resistance<br/>
482, 523<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Glycylglycyl-<i>N</i>-phosphonoacetylornithine resistance<br/>
604<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Canavanine + azauracil resistance<br/>
605<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Canavanine + thiouracil resistance<br/>
605<br/>
C<br/>
<i>argR</i><br/>
E<br/>
Acetylnorvaline resistance in <i>argR</i>(Con)<br/>
402<br/>
<i>argS</i><br/>
E<br/>
Canavanine resistance<br/>
322<br/>
S<br/>
<i>argS</i><br/>
E<br/>
Mecillinam resistance (beta-lactam resistance)<br/>
802<br/>
S<br/>
<i>argT</i><br/>
S<br/>
Hydrazino (α) imidazole propionic acid resistance<br/>
432, 433<br/>
<i>aroA</i><br/>
E, S<br/>
Glyphosate resistance<br/>
512, 731, Comai<i>d</i><br/>
C, D<br/>
<i>aroF</i><br/>
E<br/>
Amino(4)phenylalanine resistance<br/>
504<br/>
C<br/>
<i>aroF</i><br/>
S<br/>
Fluoro(4)phenylalanine resistance<br/>
270, 729<br/>
C<br/>
<i>aroG</i><br/>
E, S<br/>
Methyl(3)anthranilate resistance<br/>
307<br/>
FBI, S<br/>
<i>aroG</i><br/>
E<br/>
Thienylalanine resistance<br/>
215<br/>
FBI, S<br/>
<i>aroG</i><br/>
E<br/>
Fluorophenylalanine resistance<br/>
351<br/>
FBI, S<br/>
<i>aroH</i><br/>
E<br/>
Tryptophan analog resistance<br/>
637<br/>
FBI, S<br/>
<i>aroP</i><br/>
E, S<br/>
Methyl(5)tryptophan resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L, C<br/>
<i>aroP</i><br/>
E, S<br/>
Fluoro(5)tryptophan resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L<br/>
<i>aroP</i><br/>
E, S<br/>
Azaserine resistance<br/>
12, 94, 288, 303, 393, 437–439, 836, 837<br/>
L<br/>
<i>aroP</i><br/>
E, S<br/>
Thienylalanine resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L<br/>
<i>aroP</i><br/>
E, S<br/>
Fluorophenylalanine resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L<br/>
<i>aroP</i><br/>
E, S<br/>
Azaleucine resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L<br/>
<i>aroP</i><br/>
E, S<br/>
Methyl(5)tryptophan + thienylalanaine resistance<br/>
12, 94, 288, 303, 393, 437–439<br/>
L<br/>
<i>aroT</i><br/>
E, S<br/>
Indole acrylic acid resistance<br/>
769<br/>
L<br/>
<i>aroT</i><br/>
E<br/>
Methyl(4)tryptophan resistance in <i>aroP</i><br/>
594<br/>
L<br/>
<i>asm</i><br/>
S<br/>
Methionine sulfoxamine resistance<br/>
188<br/>
<i>atoB</i><br/>
S<br/>
Dinitropyrene resistance<br/>
590<br/>
L<br/>
<i>atoC</i><br/>
E<br/>
Butyrate as C source in <i>fadR</i>(Con)<br/>
602<br/>
C<br/>
<i>atoC</i><br/>
E<br/>
Valerate as C source in <i>fadR</i>(Con)<br/>
602<br/>
C<br/>
<i>atoC</i><br/>
E<br/>
Penten(4)oate resistance in <i>atoC</i>(Con)<br/>
669<br/>
L<br/>
<i>atpA–atpE</i><br/>
E<br/>
Uncoupler resistances, including DCCD<br/>
225, 226, 229, 355, 537<br/>
L<br/>
<i>atpA–atpE</i><br/>
E<br/>
Tributyl tin resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
E<br/>
CCCP resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
E<br/>
Pentachlorophenol resistance<br/>
355<br/>
<i>atpA–atpE</i><br/>
E<br/>
Auroventin resistance<br/>
451, 685, 818<br/>
L<br/>
<i>atpA–atpE</i><br/>
E<br/>
Kanamycin resistance<br/>
768<br/>
L<br/>
<i>atpA–atpE</i><br/>
E<br/>
Neomycin resistance<br/>
392<br/>
L<br/>
<i>atpA–atpE</i><br/>
E<br/>
Azide resistance<br/>
355<br/>
<i>atr</i><br/>
S<br/>
Acid resistance<br/>
233<br/>
<i>azaAB</i><br/>
E<br/>
Azaserine resistance<br/>
836<br/>
<i>azl</i><br/>
E<br/>
Azaleucine resistance<br/>
610<br/>
<i>bglBC</i><br/>
E<br/>
Arbutin as C source<br/>
523, 616, 640<br/>
<i>bglBC</i><br/>
E<br/>
Salicin as C source<br/>
523, 616, 640<br/>
<i>bglT</i><br/>
E<br/>
Methyl(β)glucoside as C source<br/>
686<br/>
C<br/>
<i>bio</i> operon<br/>
E<br/>
Dehydrobiotin resistance<br/>
206<br/>
<i>bioP</i><br/>
E<br/>
Dehydrobiotin resistance<br/>
206<br/>
L<br/>
<i>birA</i><br/>
E<br/>
Dehydrobiotin resistance<br/>
206, 597<br/>
<i>brnQ</i><br/>
E<br/>
Methyl(<i>o</i>)threonine resistance<br/>
278<br/>
L<br/>
<i>brnQ</i><br/>
E<br/>
Valine resistance<br/>
277<br/>
L<br/>
<i>btuB</i><br/>
E<br/>
Colicin E3 tolerance<br/>
46, 47, 109, 284, 388, 620<br/>
<i>btuB</i><br/>
E, S<br/>
Bf23 phage resistance<br/>
46, 47, 109, 284, 388, 528, 620<br/>
<i>bymA</i><br/>
E<br/>
Maltose utilization in <i>malT</i><br/>
327<br/>
<i>cbt</i><br/>
E<br/>
Chloroacetate(β) resistance<br/>
68<br/>
L<br/>
<i>cbt</i><br/>
E<br/>
Colicin B tolerance<br/>
623<br/>
L<br/>
<i>cbt</i><br/>
E<br/>
Colicin D tolerance<br/>
623<br/>
L<br/>
<i>cdd</i><br/>
E<br/>
Aza(5)-2′-deoxycytidine resistance<br/>
196<br/>
L<br/>
<i>cdd</i><br/>
E, S<br/>
Fluoro(5)deoxycytidine resistance<br/>
53, 579<br/>
L<br/>
<i>celABCDF</i><br/>
E<br/>
Cellobiose as C source<br/>
426<br/>
<i>cet</i><br/>
E<br/>
Colicin E2 tolerance<br/>
201<br/>
<i>che</i><br/>
S<br/>
Migration in a chemotaxis gradient<br/>
34<br/>
<i>chlABDEG</i><br/>
E, S<br/>
Chlorate resistance<br/>
2, 121, 122, 228, 266, 523, 743, 744<br/>
L<br/>
<i>chlABDE</i><br/>
E<br/>
Lactate + fumarate as anaerobic energy source<br/>
436<br/>
L<br/>
<i>chlC</i><br/>
S<br/>
Chlorate resistance<br/>
45<br/>
L<br/>
<i>chlE</i><br/>
E<br/>
Lactate + nitrate as anaerobic energy source<br/>
799<br/>
<i>chlE</i><br/>
E<br/>
Biotin sulfoxide utilization in <i>chl bio</i><br/>
180<br/>
<i>cirA</i><br/>
E<br/>
Colicin I resistance<br/>
77, 93, 620<br/>
L<br/>
<i>cirA</i><br/>
E<br/>
Siderophore–beta-lactam conjugate resistance<br/>
93<br/>
L<br/>
<i>cit</i><br/>
E<br/>
Citrate as C source<br/>
290<br/>
<i>cls</i><br/>
E<br/>
Dihydroxy(3,4)butyl-1-phosphonate resistance<br/>
345<br/>
L<br/>
<i>cmlA</i><br/>
E<br/>
Chloramphenicol resistance<br/>
48<br/>
<i>cmlA</i><br/>
E<br/>
Tetracycline resistance<br/>
523, 638<br/>
<i>coaA</i><br/>
E<br/>
Coenzyme A feedback resistance<br/>
789, 790<br/>
FBI, S<br/>
<i>codA</i>(<i>cod</i>)<br/>
E, S<br/>
Fluoro(5)cytosine resistance<br/>
4, 54<br/>
L<br/>
<i>corABCD</i><br/>
E, S<br/>
Cobalt resistance<br/>
262, 600, 817<br/>
<i>corABCD</i><br/>
E<br/>
Manganese resistance<br/>
600<br/>
<i>corABCD</i><br/>
E<br/>
Nickel resistance<br/>
817<br/>
<i>cpd</i><br/>
S<br/>
Succinate as improved C source<br/>
8, 530<br/>
L<br/>
<i>cpd</i><br/>
S<br/>
Citrate as C source in presence of low cAMP<br/>
8<br/>
L<br/>
<i>cpdB</i><br/>
E<br/>
Fluorouracil(5) and 3′-AMP resistance<br/>
51<br/>
L<br/>
<i>cpxA</i><br/>
E<br/>
Amikacin resistance<br/>
629<br/>
<i>cpxA</i><br/>
E<br/>
Colicin A tolerance<br/>
629<br/>
<i>cpxA</i><br/>
E<br/>
Kanamycin resistance<br/>
768<br/>
<i>cpxA</i><br/>
E<br/>
Q phage resistance<br/>
508, 711<br/>
<i>cpxA</i><br/>
E<br/>
Serine (L) as C source<br/>
567<br/>
<i>crg</i><br/>
E<br/>
Cold-resistant growth<br/>
398<br/>
<i>crp</i><br/>
S<br/>
Fosfomycin resistance<br/>
10<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Serine (L) resistance in <i>relA</i><br/>
167<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Lambda phage + nalidixic acid resistance<br/>
429<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Streptomycin + cAMP resistance<br/>
31<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Lambda phage resistance with maltose and arabinose as C sources<br/>
92, 766<br/>
L<br/>
<i>crp</i><br/>
E<br/>
cAMP + glucose 6-phosphate resistance<br/>
1a<br/>
L<br/>
<i>crp</i><br/>
E<br/>
cAMP + glucose 6-phosphate + D-xylose + L-arabinose resistance<br/>
1a<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Fluorouracil(5) + 5′-AMP + 3′-AMP resistance<br/>
52<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Osmotolerance<br/>
282<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Beta-lactam resistance<br/>
362<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Mecillinam resistance<br/>
25, 168, 857<br/>
L<br/>
<i>crp</i><br/>
E<br/>
UV light resistance<br/>
627<br/>
L<br/>
<i>crp</i><br/>
E<br/>
Rifampin resistance<br/>
413<br/>
L<br/>
<i>crp</i><br/>
E<br/>
T6 phage resistance<br/>
6<br/>
L<br/>
<i>crr</i><br/>
E<br/>
Thio(5)glucose resistance<br/>
419<br/>
L<br/>
<i>crr</i><br/>
S<br/>
Methylglucoside(α)-resistant utilization of glycerol in <i>ptsHI</i><br/>
563<br/>
L<br/>
<i>cxm</i><br/>
E<br/>
Xylose (D) + cAMP resistance<br/>
1a<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Lambda phage resistance with maltose and arabinose as C sources<br/>
92<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Lambda phage + nalidixic acid resistance<br/>
429<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Serine (L) resistance in <i>relA</i><br/>
167<br/>
L<br/>
<i>cyaA</i><br/>
S<br/>
Fosfomycin resistance<br/>
10<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Osmotolerance<br/>
282<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Beta-lactam resistance<br/>
362<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Mecillinam resistance<br/>
25, 168, 857<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
UV light resistance<br/>
627<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
Rifampin resistance<br/>
413<br/>
L<br/>
<i>cyaA</i><br/>
E<br/>
T6 phage resistance<br/>
6<br/>
L<br/>
<i>cycA</i><br/>
E<br/>
Cycloserine (D) resistance<br/>
150, 646, 813<br/>
L<br/>
<i>cycA</i><br/>
E<br/>
Serine (D) resistance<br/>
689<br/>
L<br/>
<i>cysA</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysA</i><br/>
E<br/>
Selenate resistance<br/>
728<br/>
L<br/>
<i>cysA</i><br/>
S<br/>
Azaserine resistance<br/>
340, 689<br/>
L<br/>
<i>cysB</i><br/>
S<br/>
Chromate resistance<br/>
340<br/>
L<br/>
<i>cysB</i><br/>
S<br/>
Azide resistance<br/>
227<br/>
C<br/>
<i>cysB</i><br/>
S<br/>
Selenate resistance<br/>
339<br/>
L<br/>
<i>cysB</i><br/>
E<br/>
Novobiocin resistance<br/>
631<br/>
L<br/>
<i>cysB</i><br/>
S<br/>
Triazole resistance<br/>
227<br/>
C<br/>
<i>cysB</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysC</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysC</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysD</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysD</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysE</i><br/>
S<br/>
Triazole resistance in <i>cysM</i><br/>
717, 825<br/>
C<br/>
<i>cysE</i><br/>
S<br/>
Triazole resistance<br/>
341<br/>
C<br/>
<i>cysE</i><br/>
E<br/>
Novobiocin resistance<br/>
631<br/>
L<br/>
<i>cysG</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysH</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysH</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysI</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysI</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysJ</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cysJ</i><br/>
S<br/>
Chromate resistance<br/>
581<br/>
L<br/>
<i>cysK</i><br/>
S, E<br/>
Azaserine resistance<br/>
340, 827<br/>
L<br/>
<i>cysK</i><br/>
S<br/>
Azide resistance<br/>
147, 227<br/>
L<br/>
<i>cysK</i><br/>
E<br/>
Selenate resistance<br/>
230<br/>
L<br/>
<i>cysK</i><br/>
E, S<br/>
Triazole resistance<br/>
147, 227, 826, 827<br/>
L, C<br/>
<i>cysK</i><br/>
E<br/>
Selenite resistance<br/>
230<br/>
L<br/>
<i>cysL</i><br/>
S<br/>
Selenate resistance<br/>
673, 674<br/>
<i>cysL</i><br/>
S<br/>
Chromate + selenate resistance<br/>
338<br/>
<i>cysM</i><br/>
S<br/>
Azaserine resistance<br/>
340<br/>
L<br/>
<i>cytR</i><br/>
E<br/>
Uridine as C source, improved utilization<br/>
546<br/>
<i>dadA</i><br/>
E, S<br/>
Chloro(β)-D-alanine resistance<br/>
832<br/>
L<br/>
<i>dadA</i><br/>
E, S<br/>
D-Amino acid satisfaction of amino acid auxotrophy<br/>
428, 831<br/>
C<br/>
<i>dcm</i><br/>
E<br/>
Aza(5)cytidine resistance<br/>
247<br/>
L<br/>
<i>dct</i><br/>
E<br/>
Fluoro(3)malate resistance<br/>
401<br/>
L<br/>
<i>dct</i><br/>
E<br/>
Tartrate resistance<br/>
687<br/>
L<br/>
<i>dct</i><br/>
S<br/>
Malate (L) as improved C source<br/>
745<br/>
D<br/>
<i>deoA</i><br/>
E<br/>
Deoxyadenosine + fluorouracil resistance in <i>upp</i><br/>
3<br/>
L<br/>
<i>deoA</i><br/>
E<br/>
Thymidine resistance in <i>deoC</i><br/>
3<br/>
<i>deoB</i><br/>
E<br/>
Thymidine resistance in <i>deoC</i><br/>
3, 651<br/>
L<br/>
<i>deoB</i><br/>
E, S<br/>
Thymineless death prevention by low thymine levels in <i>thyA</i><br/>
71, 471<br/>
<i>deoC</i><br/>
E<br/>
Thymineless death prevention by low thymine levels in <i>thyA</i><br/>
325, 471, 651<br/>
L<br/>
<i>deoD</i><br/>
E<br/>
Deoxy(2)adenosine resistance in <i>deoC</i><br/>
651<br/>
L<br/>
<i>deoD</i><br/>
E<br/>
Deoxyadenosine + fluorouracil resistance in <i>upp</i><br/>
3<br/>
L<br/>
<i>deoR</i><br/>
E<br/>
Inosine as improved C source<br/>
546<br/>
C<br/>
<i>deoR</i><br/>
S<br/>
Diamino(2,6)purine satisfaction of purine auxotrophy<br/>
251<br/>
<i>deoR</i><br/>
S<br/>
Uridine resistance in <i>thyA deoB</i><br/>
71<br/>
<i>dgd</i><br/>
E<br/>
Arabitol (D) as C source in <i>fuc</i><br/>
849<br/>
<i>dgoR</i><br/>
E<br/>
Keto(2)-3-deoxygalactonate as C source<br/>
144<br/>
C<br/>
<i>dgsA</i><br/>
E<br/>
Glucosamine as anaerobic C source in <i>ptsG</i><br/>
652<br/>
L<br/>
<i>dhuA</i><br/>
E, S<br/>
Histidine (D) satisfaction of <i>his</i> auxotrophs<br/>
422, 428, 546<br/>
<i>dhuA</i><br/>
S<br/>
Azaserine + tryptophan resistance<br/>
432<br/>
<i>dld</i><br/>
E<br/>
Vinylglycolate resistance<br/>
696<br/>
L<br/>
<i>dml</i><br/>
S<br/>
Malate (D) as C source<br/>
737<br/>
<i>dnaB</i><br/>
E<br/>
Lambdoid phage mixture coinfection resistance<br/>
259<br/>
<i>dnaB</i><br/>
E<br/>
Phenethyl alcohol resistance<br/>
494<br/>
<i>dnaE</i><br/>
E<br/>
Acriflavin (acridine) resistance<br/>
553–555<br/>
<i>dnaE</i><br/>
E<br/>
Globomycin resistance<br/>
668<br/>
S<br/>
<i>dnaJ</i><br/>
E<br/>
Lambda phage induction, resistance to<br/>
667<br/>
S<br/>
<i>dnaJ</i><br/>
E<br/>
Lambdoid phage mixture coinfection resistance<br/>
257, 259<br/>
S<br/>
<i>dnaJ</i><br/>
E<br/>
P2 phage + lambda phage coinfection resistance<br/>
753<br/>
S<br/>
<i>dnaK</i><br/>
E<br/>
Lambda phage induction, resistance to<br/>
667<br/>
S<br/>
<i>dnaK</i><br/>
E<br/>
Lambdoid phage mixture coinfection resistance<br/>
257, 259<br/>
S<br/>
<i>dnaK</i><br/>
E<br/>
P2 phage + lambda phage coninfection resistance<br/>
753<br/>
S<br/>
<i>dnaP</i><br/>
E<br/>
Phenethyl alcohol resistance<br/>
809<br/>
<i>dor</i><br/>
S<br/>
Drug-resistant gene maintenance<br/>
814<br/>
<i>dppA</i><br/>
E, S<br/>
Bacilysin resistance<br/>
1<br/>
L<br/>
<i>dppA</i><br/>
E, S<br/>
Bialaphos resistance<br/>
1<br/>
L<br/>
<i>dppA</i><br/>
E, S<br/>
Valine-containing dipeptide resistance<br/>
1<br/>
L<br/>
<i>dppA</i><br/>
E<br/>
Lysyl-2-aminoxypropionate resistance<br/>
603<br/>
L<br/>
<i>dppA</i><br/>
E<br/>
Glycylleucine resistance<br/>
269<br/>
L<br/>
<i>dppA</i><br/>
E<br/>
Phenylalanylleucine resistance<br/>
269<br/>
L<br/>
<i>dppA</i><br/>
E<br/>
Glycylvaline resistance in <i>opp</i><br/>
178<br/>
L<br/>
<i>dsdA</i><br/>
E<br/>
Sucrose as C source<br/>
5<br/>
L<br/>
<i>dsdC</i><br/>
E<br/>
Sucrose as C source<br/>
5<br/>
<i>ebgA</i><br/>
E<br/>
Lactose utilization in ∆<i>lacZ</i><br/>
118<br/>
Q<br/>
<i>ecfB</i><br/>
E<br/>
Serine (L) as C source<br/>
567, 768<br/>
<i>ecfB</i><br/>
E<br/>
Kanamycin resistance<br/>
567, 768<br/>
<i>ecfB</i><br/>
E<br/>
Neomycin resistance<br/>
608<br/>
<i>ecfB</i><br/>
E<br/>
Colicin K resistance<br/>
608<br/>
<i>edd</i><br/>
E<br/>
Gluconate as C source in <i>eda</i><br/>
239, 240<br/>
L<br/>
<i>emrB</i><br/>
E<br/>
CCCP resistance due to gene dosage<br/>
472<br/>
D<br/>
<i>emrB</i><br/>
E<br/>
Nalidixic acid resistance due to gene dosage<br/>
472<br/>
D<br/>
<i>emrB</i><br/>
E<br/>
Thiolactomycin resistance due to gene dosage<br/>
250<br/>
D<br/>
<i>emrB</i><br/>
E<br/>
Thiolactomycin resistance<br/>
250<br/>
<i>envB</i><br/>
E, S<br/>
Mecillinam resistance<br/>
359, 587<br/>
<i>envB</i><br/>
E<br/>
UV light resistance<br/>
24<br/>
<i>envM</i><br/>
E, S<br/>
Diazoborine resistance<br/>
63<br/>
S<br/>
<i>envZ</i><br/>
E<br/>
Ampicillin resistance<br/>
362, 363<br/>
<i>envZ</i><br/>
E<br/>
Colicin L tolerance<br/>
812<br/>
<i>envZ</i><br/>
E<br/>
Lambda phage resistance<br/>
812<br/>
<i>envZ</i><br/>
E<br/>
Me1 phage resistance<br/>
801<br/>
<i>envZ</i><br/>
E<br/>
TPI phage resistance<br/>
812<br/>
<i>envZ</i><br/>
E<br/>
TuIa phage resistance<br/>
801<br/>
<i>envZ</i><br/>
E<br/>
Freeze-thaw resistance<br/>
112<br/>
<i>envZ</i><br/>
E<br/>
Colicin (multiple) resistance<br/>
626<br/>
<i>eryC</i><br/>
E<br/>
Erythromycin resistance<br/>
599<br/>
<i>eryD</i><br/>
E<br/>
Erythromycin resistance<br/>
830<br/>
<i>exbB</i><br/>
E<br/>
Albomycin resistance<br/>
205<br/>
<i>exbB</i><br/>
E<br/>
Colicin I resistance<br/>
283, 624<br/>
<i>exbB</i><br/>
E<br/>
Colicin (other) resistance<br/>
283, 624<br/>
<i>exbC</i><br/>
E<br/>
Colicin B resistance<br/>
624<br/>
<i>exbC</i><br/>
E<br/>
Colicin I resistance<br/>
283, 624<br/>
<i>exbC</i><br/>
E<br/>
Colicin (other) resistance<br/>
283, 624<br/>
<i>exuR</i><br/>
E<br/>
Aldohexuronate resistance in <i>eda</i><br/>
612<br/>
<i>exuR</i><br/>
E<br/>
Hexuronate as C course in noninducible <i>exuR eda</i><br/>
612<br/>
C<br/>
<i>exuT</i><br/>
E<br/>
Aldohexuronate resistance in <i>eda</i><br/>
612<br/>
L<br/>
<i>fadB</i><br/>
E<br/>
Thiolactomycin resistance (due to gene dosage)<br/>
778<br/>
D<br/>
<i>fadL</i><br/>
E<br/>
T2 phage resistance in <i>ompF</i>+ or <i>ompF</i><br/>
70, 534<br/>
L<br/>
<i>fadR</i><br/>
E<br/>
Decanoate as C source<br/>
713<br/>
L<br/>
<i>fba</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>fepABCDG</i><br/>
E<br/>
Colicin B resistance<br/>
623, 624<br/>
L<br/>
<i>fepABDCG</i><br/>
E<br/>
Colicin D resistance<br/>
623<br/>
L<br/>
<i>fhuA</i><br/>
E, S<br/>
Albomycin resistance<br/>
87, 387, 388, 478,479<br/>
S<br/>
<i>fhuA</i><br/>
S<br/>
ES18 phage resistance<br/>
87, 478, 479<br/>
S<br/>
<i>fhuA</i><br/>
E<br/>
T1 phage resistance<br/>
93, 409, Lin et al.<i>e</i><br/>
S, L<br/>
<i>fhuA</i><br/>
E<br/>
T5 phage resistance<br/>
93, 151, 387, Lin et al.<i>e</i><br/>
L<br/>
<i>fhuA</i><br/>
E<br/>
Φ80 phage resistance<br/>
151, 387, 409, Lin et al.<i>e</i><br/>
L, S<br/>
<i>fhuA</i><br/>
E<br/>
Colicin M resistance<br/>
151, 387, 409<br/>
L, S<br/>
<i>fhuA</i><br/>
E<br/>
Beta-lactam conjugate resistance<br/>
93<br/>
L<br/>
<i>fhuB</i><br/>
E<br/>
Albomycin resistance<br/>
618<br/>
L<br/>
<i>fliC</i><br/>
E, S<br/>
Chi phage resistance<br/>
347, 349, 416, 417, 513, 710<br/>
<i>fliC</i><br/>
S<br/>
Prolonged static cultivation<br/>
249<br/>
<i>flrB</i><br/>
S<br/>
Trifluoroleucine resistance<br/>
115, 117<br/>
<i>folA</i><br/>
E<br/>
Sulfonamide resistance<br/>
607, 697<br/>
S, D<br/>
<i>folA</i><br/>
S<br/>
Trimethoprim resistance<br/>
405, 654, 718, 719<br/>
S, D<br/>
<i>folP</i><br/>
E<br/>
Sulfonamide resistance<br/>
756<br/>
S<br/>
<i>fruA</i><br/>
E<br/>
Deoxy(2)glucose-independent fructose utilization<br/>
11<br/>
<i>fruA</i><br/>
E<br/>
Xylitol resistance<br/>
614, 639<br/>
L<br/>
<i>fruA</i><br/>
E<br/>
Sorbose (L) resistance<br/>
715<br/>
L<br/>
<i>fts</i> (generic)<br/>
E<br/>
Filter retention<br/>
55<br/>
<i>ftsZ</i><br/>
E<br/>
UV irradiation resistance in <i>lon</i><br/>
373<br/>
<i>ftsZ</i><br/>
E<br/>
Methyl methanesulfonate resistance in <i>lon</i><br/>
373<br/>
<i>ftsZ</i><br/>
E<br/>
Nitrofurantoin resistance in <i>lon</i><br/>
252<br/>
<i>fucA</i><br/>
E<br/>
Propanediol as C source<br/>
287<br/>
<i>fucA</i><br/>
E<br/>
Ethyleneglycol as C source in propanediol utilizer<br/>
79<br/>
<i>fucA</i><br/>
E<br/>
Fucose (L) as C source in propanediol utilizer<br/>
287<br/>
<i>fucA</i><br/>
E<br/>
Xylitol as C source in propanediol utilizer<br/>
848<br/>
<i>fucA</i><br/>
E<br/>
Arabinose (D) as C source<br/>
450<br/>
<i>fur</i><br/>
E<br/>
Manganese resistance<br/>
300<br/>
C<br/>
<i>fusA</i><br/>
E<br/>
Fusidic acid resistance<br/>
65, 434, 695, 761<br/>
S<br/>
<i>gabC</i><br/>
E<br/>
Aminobutyrate as N source<br/>
197<br/>
<i>gadS</i><br/>
E<br/>
Glutamate as C source<br/>
292<br/>
L<br/>
<i>gal</i> operon<br/>
E<br/>
Galactose utilization in the presence of thiomethylglucoside<br/>
636<br/>
D<br/>
<i>gal</i> operon<br/>
S<br/>
Deoxy(2)galactose resistance<br/>
9, 552<br/>
L<br/>
<i>gal</i> operon<br/>
E<br/>
Galactose resistance in <i>galU</i><br/>
664<br/>
L<br/>
<i>galC</i><br/>
S<br/>
Glucose as C source in ∆<i>ptsHI</i><br/>
613<br/>
<i>galE</i><br/>
E, S<br/>
P1 phage infection of <i>Salmonella</i> sp. monitored by drug resistance<br/>
527<br/>
L<br/>
<i>galE</i><br/>
E<br/>
U3 phage resistance<br/>
816<br/>
L<br/>
<i>galE</i><br/>
S<br/>
Deoxy(2)galactose resistance<br/>
408<br/>
L<br/>
<i>galE</i><br/>
S<br/>
Felix O phage resistance<br/>
334, 527, 591, 833<br/>
L<br/>
<i>galE</i><br/>
S<br/>
P22 phage resistance<br/>
334, 527, 591, 833<br/>
L<br/>
<i>galK</i><br/>
S<br/>
Deoxy(2)galactose resistance<br/>
408<br/>
L<br/>
<i>galK</i><br/>
E, S<br/>
Galactose resistance in <i>galE</i><br/>
569, 752<br/>
L<br/>
<i>galK</i><br/>
E<br/>
Galactose resistance in <i>galT</i><br/>
859<br/>
L<br/>
<i>galK</i><br/>
E<br/>
Galactose resistance in <i>galU</i><br/>
664<br/>
L<br/>
<i>galP</i><br/>
S<br/>
Deoxy(2)galactose resistance<br/>
552<br/>
L<br/>
<i>galR</i><br/>
E<br/>
Thiomethylgalactoside-independent utilization of galactose in <i>galR</i>(Con)<br/>
108<br/>
<i>galR</i><br/>
S<br/>
Glucose utilization in ∆<i>ptsHI</i><br/>
613<br/>
<i>galR</i><br/>
E<br/>
Galactose resistance in <i>galT</i>+<i>K</i>+<i>E</i>+/<i>galT</i>+<i>K</i>+<i>E</i>+ <i>galU</i><br/>
664<br/>
<i>galT</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>galU</i><br/>
E<br/>
Ampicillin resistance<br/>
212<br/>
L<br/>
<i>galU</i><br/>
E<br/>
P1 phage resistance<br/>
242<br/>
L<br/>
<i>galU</i><br/>
E<br/>
U3 phage resistance<br/>
816<br/>
L<br/>
<i>galU</i><br/>
S<br/>
Felix O phage resistance<br/>
334<br/>
L<br/>
<i>garA</i><br/>
S<br/>
Gamma irradiation resistance<br/>
346<br/>
<i>garA</i><br/>
E<br/>
Glucarate (D) resistance in <i>ppc</i><br/>
647<br/>
L<br/>
<i>garB</i><br/>
S<br/>
Gamma irradiation resistance<br/>
346<br/>
<i>gatACD</i><br/>
E<br/>
Fucitol resistance in galactitol-utilizing strains<br/>
184<br/>
L<br/>
<i>gatACD</i><br/>
E<br/>
Deoxy(2)galactitol resistance in galactitol-utilizing strains<br/>
184<br/>
L<br/>
<i>gatACD</i><br/>
E<br/>
Arabitol utilization<br/>
466, 845<br/>
<i>gatACD</i><br/>
E<br/>
Ribitol utilization<br/>
466, 845<br/>
<i>gatACD</i><br/>
E<br/>
Arbitol (D) resistance<br/>
639<br/>
L<br/>
<i>gleR</i><br/>
S<br/>
Glycylleucine resistance in <i>ilv</i><br/>
580<br/>
<i>glnA</i><br/>
S<br/>
Histidine(D) + glycylglutamine satisfaction of <i>his</i> auxotrophs<br/>
819<br/>
L<br/>
<i>glnA</i><br/>
E<br/>
Methylammonium resistance<br/>
694<br/>
S<br/>
<i>glnA</i><br/>
E<br/>
Methionine sulfoxamine resistance in <i>glnG</i><br/>
592<br/>
C<br/>
<i>glnA</i><br/>
S<br/>
Glutamyl(γ)hydrazide resistance<br/>
518, Miller<i>f</i><br/>
S<br/>
<i>glnF</i><br/>
S<br/>
Glutamyl(γ)hydrazide resistance<br/>
433<br/>
L<br/>
<i>glnH</i><br/>
S<br/>
433<br/>
L<br/>
Glutamyl(γ)hydrazide resistance<br/>
<i>glnP</i><br/>
E<br/>
Glutamine as C source<br/>
433, 501, 820<br/>
<i>glnP</i><br/>
E, S<br/>
Methionine sulfoxamine resistance<br/>
37, 501<br/>
L<br/>
<i>glnP</i><br/>
E<br/>
Glutamyl(γ)hydrazide resistance<br/>
501, 821<br/>
L<br/>
<i>glnP</i><br/>
E<br/>
Glutamine (D) resistance<br/>
501<br/>
L<br/>
<i>glnV</i><br/>
E<br/>
Caffeine resistance<br/>
185<br/>
S<br/>
<i>glpD</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>glpF</i><br/>
E<br/>
Glyceraldehyde (L) resistance<br/>
762<br/>
L<br/>
<i>glpK</i><br/>
E<br/>
Glyceraldehyde (L) resistance<br/>
762<br/>
L<br/>
<i>glpK</i><br/>
E, S<br/>
Methyl(α)glucoside-resistant glycerol utilization in <i>ptsI</i><br/>
64, 665<br/>
<i>glpT</i><br/>
E, S<br/>
Fosfomycin resistance<br/>
10, 29, 313, 707, 800<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Glyceraldehyde (DL) 3-phosphate resistance<br/>
762<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Arsenate resistance<br/>
838<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Dihydroxybutyl phosphonate resistance<br/>
285, 453<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Fluorohydroxyacetone phosphate resistance<br/>
515<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Chlorohydroxyacetone phosphate resistance<br/>
515<br/>
L<br/>
<i>glpT</i><br/>
E<br/>
Glycerol 3-phosphorothioate resistance<br/>
295<br/>
L<br/>
<i>gltA</i><br/>
E<br/>
Improved growth in <i>icd</i><br/>
435<br/>
L<br/>
<i>gltH</i><br/>
E<br/>
Glutamate as C source<br/>
496, 497, 687<br/>
<i>gltR</i><br/>
E<br/>
Glutamate as C source at 42°C<br/>
497<br/>
<i>gltS</i><br/>
E<br/>
Glutamate as C source<br/>
496, 687<br/>
Q<br/>
<i>gltS</i><br/>
E<br/>
Glutamate as C source<br/>
496, 497, 687<br/>
<i>gltS</i><br/>
E<br/>
Glutamate (D) resistance in <i>gltS</i> (increased)<br/>
525, 716<br/>
L<br/>
<i>gltS</i><br/>
E<br/>
Methyl(α)glutamate resistance in <i>gltS</i> (increased)<br/>
391, 525, 716<br/>
L<br/>
<i>gltS</i><br/>
E<br/>
Homocysteic acid resistance<br/>
213<br/>
L<br/>
<i>gltX</i><br/>
E<br/>
Glutamyl-γ-methyl ester resistance<br/>
425<br/>
<i>glyA</i><br/>
E<br/>
Serine + methionine + glycine resistance in <i>relA</i><br/>
783<br/>
<i>gntM</i><br/>
E<br/>
Glycerol + gluconate as C source in <i>eda</i><br/>
217<br/>
L<br/>
<i>gntR</i><br/>
E<br/>
Acetate + gluconate as C source in <i>ppc</i><br/>
39<br/>
<i>gntS</i><br/>
E<br/>
Acetate + gluconate as C source in <i>ppc</i><br/>
39<br/>
L<br/>
<i>gor</i><br/>
E<br/>
Methyl viologen tolerance<br/>
430<br/>
L<br/>
<i>gprAB</i><br/>
E<br/>
Lambda phage resistance<br/>
578, 670<br/>
<i>gpt</i><br/>
S<br/>
Aza(8)guanine resistance<br/>
272, 764<br/>
L<br/>
<i>gpt</i><br/>
E<br/>
Sulfanilamide resistance in presence of guanine<br/>
97<br/>
L<br/>
<i>groM</i><br/>
E<br/>
T7 phage resistance<br/>
427<br/>
<i>grpD</i><br/>
E<br/>
Lambda mutant prophage induction, survival of<br/>
667<br/>
<i>grpE</i><br/>
E<br/>
Lambda mutant prophage induction, survival of<br/>
667<br/>
<i>gsh</i> (generic)<br/>
E<br/>
Nitrosoguanidine resistance<br/>
693<br/>
L<br/>
<i>gsh</i> (generic)<br/>
E<br/>
Methylglyoxal resistance<br/>
548<br/>
<i>gshAB</i><br/>
E, S<br/>
Selenite resistance<br/>
423<br/>
L<br/>
<i>guaAB</i><br/>
E<br/>
Psicofuranine resistance<br/>
779<br/>
<i>guaB</i><br/>
S<br/>
Fluoro(5)uracil + fluoro(5)uridine resistance<br/>
367<br/>
L<br/>
<i>gurBCD</i><br/>
E<br/>
Glycerol + methylglucuronide a C source in <i>eda</i><br/>
572<br/>
L<br/>
<i>gyrA</i><br/>
E, S<br/>
Triazolealanine + aminotriazole resistance<br/>
660<br/>
S<br/>
<i>gyrA</i><br/>
E, S<br/>
Nalidixic acid resistance<br/>
200, 298<br/>
S<br/>
<i>gyrA</i><br/>
E<br/>
Quinolone resistance<br/>
860<br/>
S<br/>
<i>gyrA</i><br/>
E<br/>
Oxolinic acid resistance<br/>
734<br/>
S<br/>
<i>gyrA</i><br/>
E<br/>
Glucosides (β) as C source<br/>
194<br/>
<i>gyrA</i><br/>
S<br/>
Thermotolerance<br/>
200<br/>
<i>gyrB</i><br/>
S<br/>
Triaolealanine + aminotriazole resistance<br/>
660<br/>
S<br/>
<i>gyrB</i><br/>
E<br/>
Aminotriazole resistance in <i>relA</i><br/>
772<br/>
S<br/>
<i>gyrB</i><br/>
E<br/>
Novobiocin resistance<br/>
255<br/>
S<br/>
<i>gyrB</i><br/>
E<br/>
Coumermycin resistance<br/>
181, 255, 593<br/>
D, S<br/>
<i>gyrB</i><br/>
E<br/>
Chlorobiocin resistance<br/>
589<br/>
<i>gyrB</i><br/>
E<br/>
Glucosides (β) as C source<br/>
194<br/>
<i>gyrB</i><br/>
E<br/>
Lambda mutant infection resistance<br/>
521<br/>
<i>gyrB</i><br/>
E<br/>
Nalidixic acid resistance<br/>
333, 855<br/>
S<br/>
<i>hem</i><br/>
E<br/>
Streptomycin resistance<br/>
57<br/>
L<br/>
(generic)<br/>
<i>hemA</i><br/>
E<br/>
Kanamycin resistance<br/>
585<br/>
L<br/>
<i>hemA</i><br/>
E, S<br/>
Neomycin resistance<br/>
683<br/>
L<br/>
<i>hemB</i><br/>
E<br/>
Kanamycin resistance<br/>
585<br/>
L<br/>
<i>hemB</i><br/>
E<br/>
Kanamycin-resistant, hemin-supported growth of <i>hemA</i><br/>
507<br/>
L<br/>
<i>hemB</i><br/>
E<br/>
Colicin K-type tolerance<br/>
83<br/>
<i>hemC</i><br/>
S<br/>
Neomycin resistance<br/>
682<br/>
L<br/>
<i>hemD</i><br/>
S<br/>
Neomycin resistance<br/>
681<br/>
L<br/>
<i>hemE</i><br/>
S<br/>
Neomycin resistance<br/>
189, 680<br/>
L<br/>
<i>hemBCF</i><br/>
E<br/>
Plate method<br/>
506<br/>
L<br/>
<i>hemG</i><br/>
E<br/>
Neomycin resistance<br/>
679<br/>
L<br/>
<i>hemL</i><br/>
E<br/>
Kanamycin resistance<br/>
350<br/>
L<br/>
<i>hflC</i><br/>
E<br/>
Lambda mutant phage resistance<br/>
56<br/>
<i>hflK</i><br/>
E<br/>
Lambda mutant phage resistance<br/>
56<br/>
<i>hflX</i><br/>
E<br/>
Lambda mutant phage resistance<br/>
56<br/>
<i>himA</i><br/>
E<br/>
Mu prophage induction, survival of<br/>
520, 522<br/>
<i>himA</i><br/>
E<br/>
Mu phage lytic growth resistance<br/>
81<br/>
<i>himA</i><br/>
E<br/>
Lambda mutant phage infection, survival of<br/>
519, 521<br/>
<i>himA (himC)</i><br/>
E<br/>
Lambda mutant phage resistance<br/>
519, 521<br/>
<i>himD</i><br/>
E<br/>
Mu prophage induction, survival of<br/>
520, 522<br/>
<i>himD</i><br/>
E<br/>
Mu phage lytic growth resistance<br/>
81<br/>
<i>hipA</i><br/>
E<br/>
Cycloserine resistance<br/>
541<br/>
<i>hipA</i><br/>
E<br/>
Ampicillin resistance<br/>
541<br/>
<i>hipA</i><br/>
E<br/>
Fosfomycin resistance<br/>
541<br/>
<i>hipQ</i><br/>
E<br/>
Norfloxacin resistance<br/>
842<br/>
<i>hipQ</i><br/>
E<br/>
Ampicillin resistance<br/>
842<br/>
<i>his</i> structural genes<br/>
E, S<br/>
Triazolealanine + aminotriazole resistance<br/>
98, 126, 658<br/>
C, Q<br/>
<i>his</i> structural genes<br/>
S<br/>
Aminotriazole resistance<br/>
20, 21<br/>
D<br/>
<i>his</i> structural genes<br/>
S<br/>
Growth at 42°C in <i>his</i>-overexpressing strain<br/>
804<br/>
Q<br/>
<i>his</i> structural genes<br/>
S<br/>
Histidinal satisfaction of <i>his</i> auxotroph requirement at 30°C<br/>
374, 375<br/>
Q<br/>
<i>his</i> structural genes<br/>
S<br/>
Histidine (D) satisfaction of <i>his</i> auxotroph requirement<br/>
374, 375<br/>
Q<br/>
<i>hisG</i><br/>
E, S<br/>
Thiazolealanine resistance<br/>
540, 698, 824<br/>
S, FBI<br/>
<i>hisG</i><br/>
S<br/>
Hydrazino (α) imidazole propionic acid resistance<br/>
699<br/>
S, FBI<br/>
<i>hisG</i><br/>
S<br/>
Histidinal satisfaction of <i>his</i> auxotroph requirement at 30°C<br/>
374, 375<br/>
L<br/>
<i>hisG</i><br/>
S<br/>
Histidine (D) satisfaction of <i>his</i> auxotroph requirement<br/>
374, 375<br/>
L<br/>
<i>hisG</i><br/>
E<br/>
Histidine-resistant adenine → guanine nucleotide<br/>
33<br/>
S,FBI<br/>
conversion in <i>deoD purF add</i><br/>
<i>hisJ</i><br/>
S<br/>
Hydrazino (α) imidazole propionic acid resistance<br/>
13, 15<br/>
L<br/>
<i>hisJ</i><br/>
S<br/>
Azaserine + tryptophan resistance in <i>dhuA</i><br/>
15, 432<br/>
<i>hisP</i><br/>
S<br/>
Hydrazino (α) imidazole propionic acid resistance in <i>dhuA</i><br/>
14, 15<br/>
L<br/>
<i>hisP</i><br/>
S<br/>
Arginine as N source<br/>
13, 15, 432<br/>
D<br/>
<i>hisQ</i><br/>
S<br/>
Hydrazino (α) imidazole propionic acid resistance<br/>
13, 15<br/>
L<br/>
<i>hisR</i><br/>
S<br/>
Triazolealanine + aminotriazole resistance<br/>
658<br/>
Q<br/>
<i>hisR</i><br/>
S<br/>
Thiazolealanine resistance<br/>
706<br/>
Q<br/>
<i>hisR</i><br/>
S<br/>
Methyl(2)histidine resistance + aminotriazole resistance<br/>
658<br/>
Q<br/>
<i>hisS</i><br/>
S<br/>
Triazolealanine + aminotriazole resistance<br/>
658<br/>
S<br/>
<i>hisS</i><br/>
S<br/>
Thiazolealanine resistance<br/>
657<br/>
S<br/>
<i>hisT</i><br/>
E, S<br/>
Triazolealanine + aminotriazole resistance<br/>
98, 148, 658, 705, 784<br/>
L<br/>
<i>hisT</i><br/>
E<br/>
Azaleucine resistance<br/>
98, 784<br/>
L<br/>
<i>hisT</i><br/>
E<br/>
Serine resistance<br/>
98, 784<br/>
L<br/>
<i>hisT</i><br/>
S<br/>
Amino(3)tyrosine resistance<br/>
148, 658, 705<br/>
L<br/>
<i>hisT</i><br/>
S<br/>
Thialysine resistance<br/>
148, 658, 705<br/>
L<br/>
<i>hisT</i><br/>
S<br/>
Trifluoroleucine resistance<br/>
148, 658, 705<br/>
L<br/>
<i>hisT</i><br/>
S<br/>
Norleucine resistance<br/>
148, 658, 705<br/>
L<br/>
<i>hisT</i><br/>
S<br/>
Hydroxy (β) leucine resistance<br/>
148, 658, 705<br/>
L<br/>
<i>hisT</i><br/>
E<br/>
Phenyl galactoside resistance of <i>lacP lacI</i> (nonsense) <i>supE</i><br/>
747<br/>
<i>hisU</i><br/>
S, E<br/>
Triazolealanine + aminotriazole resistance<br/>
23, 660<br/>
<i>hisU</i><br/>
S<br/>
Nalidixic acid resistance<br/>
593, 660<br/>
<i>hisW</i><br/>
S, E<br/>
Triazolealanine + aminotriazole resistance<br/>
23<br/>
<i>hisW</i><br/>
S<br/>
Coumermycin resistance<br/>
593, 660<br/>
<i>hpt</i><br/>
E<br/>
Mercapto(6)purine resistance in <i>gpt</i><br/>
371<br/>
<i>hpt</i><br/>
E<br/>
Sulfanilamide + hypoxanthine resistance<br/>
97<br/>
L<br/>
<i>hsd</i><br/>
E<br/>
Lambda <i>vir</i> resistance after infection with<br/>
183<br/>
L<br/>
heteromodified lambda <i>c</i>I857<br/>
<i>hsd</i><br/>
S<br/>
Lactose utilization after conjugation of <i>F</i>′<i>lac</i> into <i>Salmonella</i> sp.<br/>
103<br/>
L<br/>
<i>hut</i><br/>
S<br/>
Histidine as sole N or C source<br/>
509<br/>
<i>icdE</i><br/>
E, S<br/>
Nalidixic acid resistance<br/>
91, 311<br/>
L<br/>
<i>iclR</i><br/>
E<br/>
Butyrate or valerate as better C source<br/>
602<br/>
C<br/>
<i>iclR</i><br/>
E<br/>
Glucose or glycerol as C source in <i>ppc</i><br/>
488<br/>
<i>ileR</i><br/>
E<br/>
Trifluoroleucine resistance<br/>
412<br/>
<i>ileS</i><br/>
E<br/>
Pseudomonic acid resistance<br/>
858<br/>
S<br/>
<i>ileS</i><br/>
E<br/>
Thiaisoleucine resistance<br/>
757<br/>
S<br/>
<i>ilv</i> structural genes<br/>
S<br/>
Sulfometuron methyl + valine resistance<br/>
Epelbaum et al.<i>g</i><br/>
C<br/>
<i>ilv</i> structural genes<br/>
E<br/>
Aminobutyrate resistance<br/>
633, 780<br/>
C<br/>
<i>ilv</i> structural genes<br/>
E<br/>
Valine resistance<br/>
268<br/>
C<br/>
<i>ilv</i> structural genes<br/>
S<br/>
Cyclopentane glycine resistance<br/>
586<br/>
C<br/>
<i>ilvA</i><br/>
S<br/>
Cyclopentane glycine resistance<br/>
586<br/>
S, FBI<br/>
<i>ilvA</i><br/>
E<br/>
Glyclleucine resistance<br/>
806<br/>
S, FBI<br/>
<i>ilvA</i><br/>
S<br/>
Threonine as sole N source<br/>
106<br/>
S, FBI<br/>
<i>ilvA</i><br/>
E<br/>
Growth on minimal medium of <i>ilvA+</i> (multicopy) <i>ilvDC</i> <i>hisT</i> overcoming 2-ketobutyrate accumulation<br/>
231<br/>
L<br/>
<i>ilvB</i><br/>
E<br/>
Aminobutyrate resistance<br/>
633, 780<br/>
S, FBI<br/>
<i>ilvB</i><br/>
E<br/>
Valine resistance<br/>
633, 755<br/>
S, FBI<br/>
<i>ilvB</i><br/>
E<br/>
Glyclleucine resistance<br/>
269<br/>
S<br/>
<i>ilvB</i><br/>
E<br/>
Phenylalanylleucine resistance<br/>
269<br/>
S<br/>
<i>ilvF</i><br/>
E<br/>
Valine resistance<br/>
174, 610<br/>
G<br/>
<i>ilvG</i><br/>
E, S<br/>
Sulfometuron methyl + valine resistance<br/>
441, 851,Epelbaum et al.<i>g</i><br/>
S, Q<br/>
<i>ilvG</i><br/>
E<br/>
Valine resistance<br/>
221, 448, 720<br/>
G<br/>
<i>ilvH</i><br/>
E<br/>
Aminobutyrate resistance<br/>
633, 780<br/>
S, FBI<br/>
<i>ilvH</i><br/>
E<br/>
Valine resistance<br/>
633, 755<br/>
S, FBI<br/>
<i>ilvH</i><br/>
E<br/>
Glyclleucine resistance<br/>
269<br/>
S<br/>
<i>ilvH</i><br/>
E<br/>
Phenylalanylleucine resistance<br/>
269<br/>
S<br/>
<i>ilvI</i><br/>
E<br/>
Aminobutyrate resistance<br/>
633, 780<br/>
S<br/>
<i>ilvI</i><br/>
E<br/>
Valine resistance<br/>
633, 755<br/>
<i>ilvI</i><br/>
E<br/>
Glyclleucine resistance<br/>
269<br/>
<i>ilvI</i><br/>
E<br/>
Phenylalanylleucine resistance<br/>
269<br/>
<i>ilvJ</i><br/>
E<br/>
Valine resistance<br/>
174, 361, 649<br/>
G<br/>
<i>ilvU</i><br/>
E<br/>
Thiaisoleucine resistance<br/>
222<br/>
<i>kdgR</i><br/>
E<br/>
Keto(2)-3-deoxygluconate as C source<br/>
377, 615<br/>
C<br/>
<i>kdsA</i><br/>
S<br/>
9NA phage resistance in <i>galE</i><br/>
452, 641<br/>
<i>ksgA</i><br/>
E<br/>
Kasugamycin resistance<br/>
312, 726, 793<br/>
L<br/>
<i>ksgB</i><br/>
E<br/>
Kasugamycin resistance<br/>
238, 726<br/>
<i>ksgC</i><br/>
E<br/>
Kasugamycin resistance<br/>
861<br/>
<i>ksgD</i><br/>
E<br/>
Kasugamycin resistance<br/>
238<br/>
<i>lac</i><br/>
E<br/>
Growth in lactose-limited chemostats<br/>
330<br/>
D<br/>
<i>lacI</i>,operator<br/>
E<br/>
Methyl(α)glucoside-resistant utilization of lactose in <i>ptsH</i><br/>
665<br/>
C<br/>
<br/>
<i>lacI</i>,operator<br/>
E<br/>
Raffinose as C source<br/>
459<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Neolactose as C source<br/>
459<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Phenyl galactoside as C source<br/>
523<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Lactobionic acid as C source<br/>
440<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Lactitol as C source<br/>
457<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Melibiose as C source<br/>
475<br/>
C<br/>
<i>lacI</i>operator<br/>
E<br/>
Melibiose as C source and acetyl(<i>N</i>)lactonate as N source<br/>
475<br/>
C<br/>
<i>lacI</i>,operator<br/>
E<br/>
Lactobionic acid as C source<br/>
474<br/>
<i>lacI</i>,operator<br/>
E<br/>
Acetyl(<i>N</i>)lactonate as N source<br/>
474<br/>
Q<br/>
<i>lacI</i>,operator<br/>
E<br/>
Nitro(<i>o</i>)-phenylthiogalactoside resistance in <i>lacI</i>(Con) or <i>lacO</i>(Con)<br/>
543, 571<br/>
Q<br/>
<i>lacI</i>,operator<br/>
E<br/>
Methyl(α)glucoside-resistant lactose utilization<br/>
406<br/>
C<br/>
<i>lacY</i><br/>
E<br/>
Nitro(<i>o</i>)-phenylthiogalactoside resistance<br/>
523, 543, 721<br/>
L<br/>
<i>lacY</i><br/>
E<br/>
Phenyl galactoside resistance<br/>
376<br/>
L<br/>
<i>lacY</i><br/>
E<br/>
Phenethylyl galactoside resistance<br/>
376<br/>
L<br/>
<i>lacY</i><br/>
E<br/>
Arabinose (L) growth in the presence of <i>lac</i> operon inducer<br/>
812<br/>
L<br/>
<i>lacY</i><br/>
E<br/>
Thiodigalactoside resistance<br/>
241<br/>
<i>lacZ</i><br/>
E<br/>
Lactobionic acid as C source<br/>
440<br/>
D<br/>
<i>lacZ</i><br/>
E<br/>
Phenyl galactoside resistance<br/>
376, 500<br/>
L<br/>
<i>lacZ</i><br/>
E<br/>
Phenethylyl galactoside resistance<br/>
376, 500<br/>
L<br/>
<i>lacZ</i><br/>
E<br/>
Nitro(<i>o</i>)-phenyl galactoside resistance<br/>
376, 500<br/>
L<br/>
<i>lamB</i><br/>
E<br/>
Lambda phage resistance<br/>
88, 134, 135, 253, 644, 766<br/>
L, S<br/>
<i>lamB</i><br/>
E<br/>
K10 phage resistance<br/>
644<br/>
<i>lamB</i><br/>
E<br/>
Thio(5)maltose resistance<br/>
223<br/>
L<br/>
<i>lct</i><br/>
E<br/>
Vinylglycolate resistance<br/>
696<br/>
<i>leuA</i><br/>
S<br/>
Trifluoroleucine resistance<br/>
115<br/>
FBI, S<br/>
<i>leuJ</i><br/>
E<br/>
Trifluoroleucine resistance<br/>
575<br/>
<i>leu</i>(structural genes)<br/>
S<br/>
Trifluoroleucine resistance<br/>
115, 116<br/>
C<br/>
<i>leuS</i><br/>
S, E<br/>
Azaleucine resistance<br/>
477, 514<br/>
S<br/>
<i>leuS</i><br/>
S<br/>
Trifluoroleucine resistance<br/>
7<br/>
S<br/>
<i>leuW</i><br/>
E<br/>
Calmodulin inhibitor resistance<br/>
129<br/>
S<br/>
<i>lev</i><br/>
E<br/>
Levallorphan resistance<br/>
164<br/>
<i>lexA</i><br/>
E<br/>
Mitomycin C resistance of <i>recA</i> (SOS-induced) <i>sfi</i> <i>lexA3</i>(Con)<br/>
538<br/>
L<br/>
<i>lig</i><br/>
E<br/>
T4 phage <i>lig</i> mutant nibbling of colonies yielding <i>lig</i> overproducer<br/>
254<br/>
Q<br/>
<i>lig</i><br/>
E<br/>
T4 phage <i>lig</i> mutant resistance from <i>lig</i> overproducer<br/>
254<br/>
L<br/>
<i>linB</i><br/>
E<br/>
Lincomycin resistance<br/>
26, 343<br/>
<i>lit</i><br/>
E<br/>
T4 mutant phage resistance<br/>
143<br/>
<i>livG</i><br/>
E<br/>
Azaleucine resistance<br/>
303, 561<br/>
L<br/>
<i>livH</i><br/>
E<br/>
Valine resistance in <i>leu</i><br/>
17, 595<br/>
L<br/>
<i>livH</i><br/>
E<br/>
Azaleucine resistance<br/>
561<br/>
L<br/>
<i>livJ</i><br/>
E<br/>
Valine resistance in <i>leu</i><br/>
17, 595<br/>
L<br/>
<i>livK</i><br/>
E<br/>
Valine resistance in <i>leu</i><br/>
17, 595<br/>
L<br/>
<i>lon</i><br/>
E, S<br/>
Chlorpromazine resistance<br/>
198, 529<br/>
L<br/>
<i>lon</i><br/>
E<br/>
Promethazine resistance<br/>
529<br/>
L<br/>
<i>lpp</i><br/>
E<br/>
Globomycin resistance<br/>
140, 344, 854, 868<br/>
L<br/>
<i>lpcA</i><br/>
E<br/>
T3 phage resistance<br/>
792<br/>
L<br/>
<i>lpcA</i><br/>
E<br/>
T4 phage resistance<br/>
792<br/>
L<br/>
<i>lpcA</i><br/>
E<br/>
T7 phage resistance<br/>
792<br/>
L<br/>
<i>lpcA</i><br/>
E<br/>
P1 phage resistance<br/>
40, 41<br/>
<i>lpcB</i><br/>
E<br/>
T4 phage resistance<br/>
760<br/>
<i>lpcB</i><br/>
E<br/>
T7 phage resistance<br/>
760<br/>
<i>lrp</i><br/>
E<br/>
Leucine (D) satisfaction of <i>leu</i> auxotrophs<br/>
18, 428<br/>
<i>lysC</i><br/>
E<br/>
Aminoethylcysteine (thialysine) resistance<br/>
82, 765<br/>
S, FBI<br/>
<i>lysC</i><br/>
E<br/>
Lysine hydroxamate resistance<br/>
82, 765<br/>
S, FBI<br/>
<i>lysP</i><br/>
E<br/>
Aminoethylcysteine (thialysine) resistance<br/>
611, 736<br/>
L<br/>
<i>lysS</i><br/>
E<br/>
Aminoethylcysteine (thialysine) resistance<br/>
323<br/>
S<br/>
<i>lysS</i><br/>
E<br/>
Phenyl galactoside resistance of <i>lacI </i>q<i> lacI</i>(nonsense) lacP supL<br/>
748<br/>
<i>lyt</i><br/>
E<br/>
Beta-lactam tolerance<br/>
700<br/>
<i>mac</i><br/>
E<br/>
Erythromycin growth dependence<br/>
725<br/>
<i>malE</i><br/>
E, S<br/>
Methylglucoside(α)-resistant utilization of maltose<br/>
665<br/>
<i>malE</i><br/>
E<br/>
Thio(5)maltose resistance<br/>
223<br/>
L<br/>
<i>malF</i><br/>
E, S<br/>
Methylglucoside(α)-resistant utilization of maltose<br/>
665<br/>
<i>malF</i><br/>
E<br/>
Thio(5)maltose resistance<br/>
223<br/>
L<br/>
<i>malG</i><br/>
E, S<br/>
Methylglucoside(α)-resistant utilization of maltose<br/>
665<br/>
<i>malG</i><br/>
E<br/>
Thio(5)maltose resistance<br/>
223<br/>
L<br/>
<i>malK</i><br/>
E<br/>
Lambda phage resistance<br/>
766<br/>
L<br/>
<i>malK</i><br/>
E, S<br/>
Methylglucoside(α)-resistant utilization of maltose<br/>
177, 665<br/>
<i>malK</i><br/>
E<br/>
Thio(5)maltose resistance<br/>
223<br/>
L<br/>
<i>malP</i><br/>
E<br/>
Maltose as C source in <i>malT</i><br/>
327<br/>
<i>malQ</i><br/>
E<br/>
Maltose as C source in <i>malT</i><br/>
327<br/>
<i>malT</i><br/>
E<br/>
Lambda phage resistance<br/>
766<br/>
L<br/>
<i>malT</i><br/>
E<br/>
Thiomaltose resistance<br/>
223<br/>
L<br/>
<i>manA</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
<i>manC</i><br/>
E<br/>
Lyxose (D) as C source<br/>
738<br/>
<i>manXYZ</i><br/>
E<br/>
Phage N4 resistance<br/>
410<br/>
<i>manXYZ</i><br/>
E<br/>
Deoxyglucose resistance<br/>
158, 379<br/>
L<br/>
<i>marA</i><br/>
E<br/>
Menadionine resistance<br/>
274<br/>
<i>marA</i><br/>
E<br/>
Chloramphenicol resistance<br/>
286<br/>
<i>marA</i><br/>
E<br/>
Tetracycline resistance<br/>
286, 329<br/>
<i>mbrABCD</i><br/>
E<br/>
Camphor resistance<br/>
776, 777<br/>
<i>mdoB</i><br/>
E<br/>
Arbutin resistance in <i>dgk</i><br/>
360<br/>
L<br/>
<i>mel</i> (generic)<br/>
E<br/>
Raffinose as C source in <i>lacI</i><br/>
459<br/>
<i>mel</i> (generic)<br/>
S<br/>
Methylglucoside(α)-resistant utilization of melibiose<br/>
665<br/>
<i>melB</i><br/>
E<br/>
Deoxy(2)glucose-resistant utilization of melibiose<br/>
431<br/>
S<br/>
<i>melB</i><br/>
E<br/>
Lithium-resistant utilization of melibiose<br/>
397<br/>
S<br/>
<i>metA</i><br/>
S<br/>
Methyl(α)methionine resistance<br/>
127, 447<br/>
FBI, S<br/>
<i>metC</i> (<i>ecfA</i>?)<br/>
E<br/>
Neomycin resistance<br/>
464<br/>
<i>metC</i> (<i>ecfA</i>?)<br/>
E<br/>
Colicin K resistance<br/>
465<br/>
<i>metC</i> (<i>ecfA</i>?)<br/>
E<br/>
Chloro(β)alanine resistance<br/>
832<br/>
<i>metG</i><br/>
E<br/>
Ethionine resistance<br/>
28<br/>
S<br/>
<i>metJ</i><br/>
E, S<br/>
Ethionine resistance<br/>
447<br/>
<i>metJ</i><br/>
E<br/>
Glutamyl-γ-methyl ester resistance<br/>
425<br/>
S<br/>
<i>metJ</i><br/>
E, S<br/>
Norleucine resistance<br/>
128<br/>
<i>metJ</i><br/>
E<br/>
Methionine sulfoximine + methyl(α)methionine resistance<br/>
386<br/>
S<br/>
<i>metK</i><br/>
E, S<br/>
Ethionine resistance<br/>
275, 289, 447, 735<br/>
S<br/>
<i>metK</i><br/>
E<br/>
Glutamyl-γ-methyl ester resistance<br/>
425<br/>
S<br/>
<i>metK</i><br/>
E, S<br/>
Norleucine resistance<br/>
128, 447, 735<br/>
S<br/>
<i>metK</i><br/>
S<br/>
Methyl(α)methionine resistance<br/>
447, 735<br/>
S<br/>
<i>metL</i><br/>
E<br/>
Hydroxy (β) norvaline resistance<br/>
138<br/>
S, FBI<br/>
<i>metPD</i><br/>
E, S<br/>
Methyl(α)methionine resistance<br/>
37, 38, 386<br/>
L<br/>
<i>metPD</i><br/>
E, S<br/>
Methionine sulfoximine resistance<br/>
37, 38, 386<br/>
L<br/>
<i>mglA</i><br/>
E<br/>
Fucose + arabinose-supported growth in <i>galP</i><br/>
209, 613<br/>
<i>mglB</i><br/>
E<br/>
Fucose + arabinose-supported growth in <i>galP</i><br/>
209, 613<br/>
<i>mglC</i><br/>
E<br/>
Fucose + arabinose-supported growth in <i>galP</i><br/>
209, 613<br/>
<i>mglD</i><br/>
E<br/>
Methyl-β-galactoside-supported growth<br/>
645<br/>
C<br/>
<i>mng</i><br/>
E<br/>
Manganese resistance<br/>
708<br/>
<i>mopA</i><br/>
E<br/>
T4 phage resistance<br/>
258<br/>
S<br/>
(<i>groEL</i>)<br/><i>mopA</i><br/>
E<br/>
Lambda + 434 phage resistance<br/>
258<br/>
S<br/>
(<i>groEL</i>)<br/>
<i>mopB</i><br/>
E<br/>
T4 phage resistance<br/>
258<br/>
S<br/>
(<i>groES</i>)<br/><i>mopB</i><br/>
E<br/>
Lambda + 434 phage resistance<br/>
258<br/>
S<br/>
(<i>groES</i>)<br/>
<i>motAB</i><br/>
E<br/>
Chi phage resistance<br/>
349, 709, 710<br/>
<i>mrb</i><br/>
E<br/>
Fosfomycin resistance<br/>
800<br/>
<i>mrdA</i><br/>
E<br/>
Mecillinam resistance<br/>
759<br/>
<i>mrdB</i><br/>
E<br/>
Mecillinam resistance<br/>
358, 502, 759<br/>
<i>mreBCD</i><br/>
E<br/>
Mecillinam resistance<br/>
582, 807<br/>
<i>mtlA</i><br/>
E<br/>
Arabinitol (D) resistance<br/>
614<br/>
L<br/>
<i>mtlC</i><br/>
E<br/>
Mannitol (limiting) as C source<br/>
722<br/>
C<br/>
<i>mtr</i><br/>
E<br/>
Methyl(5)tryptophan resistance<br/>
305, 320, 523<br/>
L<br/>
<i>murZ</i><br/>
E<br/>
Fosfomycin resistance due to increased gene dosage<br/>
499<br/>
D<br/>
<i>mut</i> (generic)<br/>
E<br/>
Streptomycin resistance<br/>
309<br/>
<i>mut</i> (generic)<br/>
E<br/>
Azaserine resistance<br/>
703<br/>
<i>mut</i> (generic)<br/>
E<br/>
Chemostat growth<br/>
152<br/>
<i>mutH</i><br/>
E<br/>
Amino(2)purine resistance in <i>dam</i><br/>
267<br/>
L<br/>
<i>mutL</i><br/>
E<br/>
Amino(2)purine resistance in <i>dam</i><br/>
267<br/>
L<br/>
<i>mutS</i><br/>
E<br/>
Amino(2)purine resistance in <i>dam</i><br/>
267<br/>
L<br/>
<i>mvrC</i><br/>
E<br/>
Methyl viologen resistance<br/>
532<br/>
D<br/>
<i>nadB</i><br/>
S<br/>
Amino(6)nicotinamide resistance<br/>
142, 336<br/>
S<br/>
<i>nadD</i><br/>
S<br/>
Amino(6)nicotinamide resistance<br/>
336, 337<br/>
L<br/>
<i>nagA</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>nagA</i><br/>
E<br/>
Iodoacetylglucosamine resistance<br/>
823<br/>
L<br/>
<i>nagB</i><br/>
E<br/>
Iodoacetylglucosamine resistance<br/>
823<br/>
L<br/>
<i>nagE</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>nagE</i><br/>
E<br/>
Iodoacetylglucosamine resistance<br/>
823<br/>
L<br/>
<i>nagE</i><br/>
E<br/>
Deoxy(2)-2-iodoacetamideoglucose resistance<br/>
379<br/>
L<br/>
<i>nalB</i><br/>
E<br/>
Nalidixic acid resistance<br/>
298<br/>
<i>nalD</i><br/>
E<br/>
Nalidixic acid resistance<br/>
333<br/>
<i>nar</i> (general)<br/>
E<br/>
Metronidazole resistance<br/>
677<br/>
L<br/>
<i>narC</i><br/>
E<br/>
Chlorate resistance<br/>
266, 280<br/>
L<br/>
<i>narG</i><br/>
E<br/>
Chlorate resistance<br/>
739<br/>
L<br/>
<i>narH</i><br/>
E<br/>
Chlorate resistance<br/>
739<br/>
L<br/>
<i>ndk</i><br/>
S<br/>
Aza(8)guanine resistance<br/>
264, 650<br/>
<i>neaB</i><br/>
E, S<br/>
Neamine resistance<br/>
119, 182, 495<br/>
<i>nek</i><br/>
E<br/>
Aminoglycoside resistance<br/>
27, 342<br/>
<i>nfnA</i><br/>
E<br/>
Nitrofurantoin resistance<br/>
684<br/>
<i>nfnB</i><br/>
E<br/>
Nitrofurantoin resistance<br/>
684<br/>
<i>nfsA</i><br/>
E<br/>
Nitrofuranzone resistance<br/>
90, 505<br/>
<i>nfsB</i><br/>
E<br/>
Nitrofuranzone resistance<br/>
90, 505<br/>
<i>nhaA</i><br/>
E<br/>
Lithium resistance (multicopy)<br/>
628<br/>
D<br/>
<i>nol</i><br/>
S<br/>
Norleucine resistance<br/>
324<br/>
<i>nov</i><br/>
E<br/>
Novobiocin resistance<br/>
630<br/>
<i>nrdA</i><br/>
E<br/>
Hydroxyurea resistance<br/>
609<br/>
D<br/>
<i>nrdB</i><br/>
E<br/>
Hydroxyurea resistance<br/>
609<br/>
D<br/>
<i>nupC</i><br/>
E<br/>
Showdomycin resistance<br/>
415, 545<br/>
L<br/>
<i>nupC</i><br/>
E<br/>
Fluorouracil resistance<br/>
544<br/>
L<br/>
<i>nupC</i><br/>
E<br/>
Fluorodeoxyuridine resistance<br/>
545<br/>
L<br/>
<i>nupC</i><br/>
E<br/>
Fluoruridine resistance<br/>
544<br/>
L<br/>
<i>nupC</i><br/>
E<br/>
Fluorodeoxycytidine resistance<br/>
544<br/>
L<br/>
<i>nupG</i><br/>
E<br/>
Fluorouracil resistance<br/>
544<br/>
L<br/>
<i>nupG</i><br/>
E<br/>
Fluorodeoxyuridine resistance<br/>
545<br/>
L<br/>
<i>nupG</i><br/>
E<br/>
Fluorouridine resistance<br/>
544<br/>
L<br/>
<i>nupG</i><br/>
E<br/>
Fluorodeoxycytidine resistance<br/>
544<br/>
L<br/>
<i>nusA</i><br/>
E<br/>
Lambda prophage induction, survival of<br/>
244<br/>
<i>nusB</i><br/>
E<br/>
Lambda prophage induction, survival of<br/>
245, 260<br/>
<i>nusB</i><br/>
E<br/>
Lambdoid phage resistance<br/>
260<br/>
<i>nuvA</i><br/>
E, S<br/>
Near-UV irradiation resistance<br/>
424, 468, 767<br/>
L<br/>
<i>nuvC</i><br/>
E<br/>
Near-UV irradiation resistance<br/>
663<br/>
<i>ompA</i><br/>
E<br/>
K3 phage resistance<br/>
306, 489, 491, 493<br/>
L<br/>
<i>ompA</i><br/>
E<br/>
T-even-like phage resistance<br/>
199, 533, 535<br/>
S<br/>
<i>ompA</i><br/>
E<br/>
TuII* phage resistance<br/>
171, 314, 493<br/>
L<br/>
<i>ompA</i><br/>
E<br/>
Ox2 phage resistance<br/>
199, 493, 642<br/>
<i>ompA</i><br/>
E<br/>
Bacteriocin JF246 resistance<br/>
124, 491<br/>
<i>ompA</i><br/>
S<br/>
Bacteriocin 4-59 resistance<br/>
741<br/>
L<br/>
<i>ompA</i><br/>
E<br/>
Colicin K tolerance<br/>
491<br/>
<i>ompA</i><br/>
E<br/>
Colicin L tolerance<br/>
491<br/>
<i>ompA</i><br/>
E<br/>
Chelator resistance<br/>
493<br/>
<i>ompA</i><br/>
E<br/>
Novobiocin resistance<br/>
493<br/>
<i>ompB</i><br/>
S<br/>
PH51 phage resistance<br/>
372<br/>
<i>ompB</i><br/>
S<br/>
PH105 phage resistance<br/>
372<br/>
<i>ompC</i><br/>
E<br/>
Me1 phage resistance<br/>
791, 801<br/>
L<br/>
<i>ompC</i><br/>
E<br/>
TuIa phage resistance<br/>
801<br/>
L<br/>
<i>ompC</i><br/>
S<br/>
PH51 phage resistance<br/>
372<br/>
L<br/>
<i>ompC</i><br/>
S<br/>
PH105 phage resistance<br/>
372<br/>
L<br/>
<i>ompC</i><br/>
E<br/>
Host range <i>Serratia marcescens</i> phage resistance<br/>
702<br/>
<i>ompD</i><br/>
S<br/>
PH51 phage resistance<br/>
741<br/>
L<br/>
<i>ompD</i><br/>
S<br/>
Bacteriocin 4-59 resistance<br/>
741<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Beta-lactam (ampicillin, cefoxitin) resistance<br/>
362, 363<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Chloramphenicol resistance<br/>
235, 523<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Tetracycline resistance<br/>
235, 523<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Fluoro(5)uracil + nucleotide resistance<br/>
52<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Colicin A tolerance<br/>
125, 235<br/>
<i>ompF</i><br/>
E<br/>
Cloacin DF13 resistance<br/>
846<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Colicin L tolerance<br/>
235, 291<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Colicin K tolerance<br/>
235<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Colicin E2 tolerance<br/>
235<br/>
<i>ompF</i><br/>
E<br/>
Colicin E3 tolerance<br/>
235<br/>
<i>ompF</i><br/>
E<br/>
Me1 phage resistance<br/>
801<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
TuIa phage resistance<br/>
801<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
TuIb phage resistance<br/>
237<br/>
<i>ompF</i><br/>
S<br/>
PH51 phage resistance<br/>
372<br/>
L<br/>
<i>ompF</i><br/>
S<br/>
PH105 phage resistance<br/>
372<br/>
L<br/>
<i>ompF</i><br/>
E<br/>
Copper resistance in <i>ompC</i><br/>
480<br/>
<i>ompR</i><br/>
E<br/>
Me1 phage resistance<br/>
801<br/>
<i>ompR</i><br/>
E<br/>
TuIa phage resistance<br/>
801<br/>
<i>ompR</i><br/>
E<br/>
Copper resistance<br/>
52, 625<br/>
<i>ompR</i><br/>
E<br/>
Beta-lactam (ampicillin, cefoxitin) resistance<br/>
362, 363<br/>
L<br/>
<i>ompR</i><br/>
E<br/>
Chloramphenicol resistance<br/>
625<br/>
<i>ompR</i><br/>
E<br/>
Fluoro(5)uracil + nucleotide resistance<br/>
52<br/>
<i>oppA</i><br/>
E, S<br/>
Triornithine resistance<br/>
43, 317<br/>
L<br/>
<i>oppA</i><br/>
E<br/>
Glycylleucine resistance<br/>
806<br/>
L<br/>
<i>oppA</i><br/>
E<br/>
Alanyl-2-aminopropionate resistance<br/>
603<br/>
L<br/>
<i>oppA</i><br/>
E, S<br/>
Trilysine resistance<br/>
317<br/>
L<br/>
<i>oppA</i><br/>
E, S<br/>
Norleucylglycyl glycine resistance<br/>
317<br/>
L<br/>
<i>oppA</i><br/>
S<br/>
Glycylglycyl histidinol phosphate ester resistance<br/>
317<br/>
L<br/>
<i>oppA</i><br/>
E, S<br/>
Phaseolotoxin resistance<br/>
733<br/>
L<br/>
<i>oppA</i><br/>
E<br/>
Tripeptide (toxic amino acid containing) resistance<br/>
604<br/>
L<br/>
<i>oppA</i><br/>
E<br/>
Glycylglycyl-<i>N</i>-<i>S</i>-(phosphonoacetyl)-L-ornithine resistance<br/>
604<br/>
L<br/>
<i>oppE</i><br/>
E<br/>
Tripeptide (toxic amino acid containing) resistance<br/>
22<br/>
L<br/>
<i>optA</i><br/>
E<br/>
T7 phage gene 1.2 mutant resistance<br/>
666<br/>
<i>osmB</i><br/>
E<br/>
Osmotolerance<br/>
384<br/>
L<br/>
<i>osmZ</i><br/>
E<br/>
Arbutin as C source<br/>
179<br/>
<i>osmZ</i><br/>
E<br/>
Salicin as C source<br/>
179<br/>
<i>oxyR</i><br/>
E, S<br/>
Peroxide resistance<br/>
131<br/>
C<br/>
<i>pab</i><br/>
E<br/>
Sulfonamide resistance<br/>
97<br/>
C<br/>
<i>pan</i><br/>
E<br/>
Salicylate resistance<br/>
481<br/>
C<br/>
<i>pan</i><br/>
E<br/>
Hydroxyaspartate resistance<br/>
701<br/>
C<br/>
<i>pan</i><br/>
E<br/>
Pentylpantothenamide resistance<br/>
136<br/>
C<br/>
<i>pdx</i><br/>
E<br/>
Isoniazid resistance<br/>
186<br/>
C<br/>
<i>pepA</i><br/>
S<br/>
Alafosfalin resistance<br/>
263<br/>
L<br/>
<i>pepA</i><br/>
E, S<br/>
Peptide (toxic, valine containing) resistance in <i>pepN</i><br/>
517<br/>
L<br/>
<i>pepD</i><br/>
E, S<br/>
Peptide (toxic, valine containing) resistance in <i>pepN</i> <i>pepA</i><br/>
517<br/>
L<br/>
<i>pepN</i><br/>
E, S<br/>
Albomycin resistance<br/>
86<br/>
L<br/>
<i>pepN</i><br/>
E, S<br/>
Peptide (toxic, valine containing) resistance<br/>
517<br/>
L<br/>
<i>pepN</i><br/>
E, S<br/>
Indicator plate<br/>
445<br/>
<i>pepQ</i><br/>
E, S<br/>
Peptide (toxic, valine containing) resistance<br/>
517<br/>
L<br/>
<i>pfkA</i><br/>
E<br/>
Streptozotocin resistance<br/>
456<br/>
L<br/>
<i>pgi</i><br/>
E<br/>
U3 phage resistance<br/>
816<br/>
L<br/>
<i>pgi</i><br/>
E<br/>
Fosfomycin + fructose-6-phosphate resistance<br/>
243<br/>
L<br/>
<i>pgm</i><br/>
E<br/>
U3 phage resistance<br/>
816<br/>
L<br/>
<i>pheA</i><br/>
E<br/>
Fluoro(4)phenylalanine resistance<br/>
351, 564<br/>
C, FBI<br/>
<i>pheR</i><br/>
S<br/>
Fluoro(4)phenylalanine resistance<br/>
271<br/>
C<br/>
<i>pheS</i><br/>
E<br/>
Fluoro(4)phenylalanine resistance<br/>
78, 218, 395<br/>
S<br/>
<i>pheS</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
394<br/>
S<br/>
<i>pheU</i><br/>
S<br/>
Fluoro(4)phenylalanine resistance<br/>
729<br/>
<i>pho</i><br/>
S<br/>
Glycerol(β)-phosphate as C source in the presence of high phosphate<br/>
407<br/>
C<br/>
<i>phoA</i><br/>
E<br/>
Fluoro(5)uracil + adenosine resistance in <i>upp, phoS,</i> or <i>phoT</i><br/>
315<br/>
<i>phoA</i><br/>
E<br/>
Glycerol(β)-phosphate as C source in the presence of high phosphate<br/>
773<br/>
C<br/>
<i>phoA</i><br/>
E<br/>
Glycerol(β)-phosphate resistance in <i>glpD</i><br/>
678<br/>
<i>phoB</i><br/>
E<br/>
Tellurite resistance<br/>
770<br/>
<i>phoB</i><br/>
E<br/>
TC45 phage resistance<br/>
771<br/>
L<br/>
<i>phoB</i><br/>
E<br/>
Fluoro(5)uracil + adenosine resistance in <i>upp, phoS,</i> or <i>phoT</i><br/>
316<br/>
<i>phoE</i><br/>
E<br/>
Acid resistance<br/>
659<br/>
D<br/>
<i>phoE</i><br/>
E<br/>
TC45 phage resistance<br/>
420, 771<br/>
S, L<br/>
<i>phoR</i><br/>
E<br/>
Arsenate resistance<br/>
852<br/>
<i>phoR</i><br/>
E<br/>
Glycerol(β)-phosphate as C source in the presence of high phosphate<br/>
204, 838<br/>
<i>phoR</i><br/>
E<br/>
TC45 phage resistance<br/>
621<br/>
S<br/>
<i>phoS</i><br/>
E<br/>
Arsenate resistance<br/>
852<br/>
<i>phoS</i><br/>
E<br/>
Glycerol(β)-phosphate as C source in the presence of high phosphate<br/>
204, 838<br/>
<i>phoS</i><br/>
E<br/>
TC45 phage resistance<br/>
621<br/>
S<br/>
<i>phoT</i><br/>
E<br/>
Arsenate resistance<br/>
852<br/>
<i>phoT</i><br/>
E<br/>
Glycerol(β)-phosphate as C source in the presence of high phosphate<br/>
204, 838<br/>
<i>phoT</i><br/>
E<br/>
TC45 phage resistance<br/>
621<br/>
S<br/>
<i>phr</i><br/>
E<br/>
T1 phage (UV irradiated) resistance<br/>
332<br/>
L<br/>
<i>phxB</i><br/>
E<br/>
φX174 phage resistance<br/>
547<br/>
L<br/>
<i>pit</i><br/>
E<br/>
Arsenate resistance<br/>
59, 727<br/>
L<br/>
<i>pldA</i><br/>
E<br/>
Actinomycin D resistance in the presence of EDTA<br/>
301, 805<br/>
L<br/>
<i>pmi</i><br/>
S<br/>
P22 phage resistance<br/>
656, 833<br/>
L<br/>
<i>pmi</i><br/>
S<br/>
9NA phage resistance<br/>
656, 833<br/>
L<br/>
<i>pmrA</i><br/>
E, S<br/>
Polymyxin resistance<br/>
219, 297, 485, 785–788<br/>
<i>pmrA</i><br/>
S<br/>
Neutrophil granule protein resistance<br/>
219<br/>
<i>pncA</i><br/>
E, S<br/>
Amino(6)nicotinamide resistance<br/>
234, 455, 822<br/>
L<br/>
<i>pncA</i><br/>
E<br/>
Nicotinamide as sole N source<br/>
598<br/>
Q<br/>
<i>pncB</i><br/>
E, S<br/>
Amino(6)nicotinamide resistance<br/>
234, 455<br/>
L<br/>
<i>pncB</i><br/>
E, S<br/>
Amino(6)nicotinate resistance<br/>
234, 455<br/>
L<br/>
<i>pncX</i><br/>
S<br/>
Amino(6)nicotinamide resistance<br/>
336<br/>
<i>pnp</i><br/>
E<br/>
Showdomycin resistance<br/>
58<br/>
<i>polA</i><br/>
E<br/>
Lambda γ mutant phage resistance<br/>
867<br/>
L<br/>
<i>praA,B</i><br/>
S<br/>
P221 phage resistance<br/>
576, 674<br/>
L<br/>
<i>praA,B</i><br/>
S<br/>
PH51 phage resistance<br/>
576<br/>
L<br/>
<i>praA,B</i><br/>
S<br/>
PH105 phage resistance<br/>
576<br/>
L<br/>
<i>prbA,B</i><br/>
S<br/>
ES18 phage resistance<br/>
674<br/>
<i>prdB</i><br/>
S<br/>
PH51 phage resistance<br/>
674<br/>
<i>prfA</i><br/>
E<br/>
Phenylgalactoside resistance of <i>lacP lacI</i>(nonsense) <i>supE</i><br/>
747<br/>
<i>prfB</i><br/>
E<br/>
Negamycin resistance<br/>
145<br/>
<i>prh</i><br/>
S<br/>
HK009 phage resistance<br/>
674<br/>
<i>prk</i><br/>
S<br/>
HK068 phage resistance<br/>
674<br/>
<i>proAB</i><br/>
S<br/>
Osmotolerance<br/>
155<br/>
<i>proA</i><br/>
E<br/>
Nitro(4)pyridine <i>N</i>-oxide resistance<br/>
62, 222, 321<br/>
L<br/>
<i>proB</i><br/>
E, S<br/>
Dehydroproline resistance<br/>
62, 155, 635<br/>
FBI, S<br/>
<i>proB</i><br/>
E<br/>
Nitro(4)pyridine <i>N</i>-oxide resistance<br/>
62, 222, 321<br/>
<i>proB</i><br/>
E, S<br/>
Azetidine carboxylate resistance<br/>
62, 155, 635<br/>
FBI, S<br/>
<i>proP</i><br/>
E, S<br/>
Dehydroproline resistance in <i>putA putP</i><br/>
156, 732<br/>
L<br/>
<i>proU</i><br/>
S<br/>
Dehydroproline + azetidine carboxylate resistance at high osmolarity in <i>putA putP</i><br/>
156<br/>
L<br/>
<i>prp</i><br/>
E<br/>
Propionate as C source<br/>
400<br/>
Q<br/>
<i>pspABCDE</i><br/>
E<br/>
Sulfanilamide + hypoxanthine resistance<br/>
97<br/>
<i>pss</i><br/>
E<br/>
Ethanol resistance<br/>
133<br/>
<i>pss</i><br/>
E<br/>
Dimethyl sulfoxide resistance<br/>
133<br/>
<i>pstABCS</i><br/>
E<br/>
Arsenate resistance<br/>
727, 838<br/>
L<br/>
<i>pstABCS</i><br/>
E<br/>
TC45 phage resistance<br/>
621<br/>
S<br/>
<i>pta</i><br/>
S<br/>
Fluoroacetate resistance<br/>
96, 281, 463, 797<br/>
<i>pts</i> (general)<br/>
E<br/>
Glucose + gluconate-independent motility<br/>
30<br/>
<i>ptsG</i><br/>
E<br/>
Methyl(α)-glucoside resistance<br/>
102, 104<br/>
<i>ptsG</i><br/>
E<br/>
Sorbose resistance<br/>
715<br/>
L<br/>
<i>ptsG</i><br/>
E, S<br/>
Deoxy(2)glucose-independent utilization of fructose<br/>
418, 510<br/>
L<br/>
<i>ptsG</i><br/>
E, S<br/>
Deoxy(3)-3-fluoroglucose-independent utilization of fructose<br/>
418, 510<br/>
L<br/>
<i>ptsG</i><br/>
E<br/>
Methyl(α)-glucoside-independent lactose + mannitol utilization<br/>
80<br/>
L<br/>
<i>ptsG</i><br/>
E<br/>
Glucosamine as C source<br/>
379<br/>
<i>ptsG</i><br/>
E<br/>
Mannose as C source<br/>
379<br/>
<i>ptsHI</i><br/>
E, S<br/>
Deoxy(3)-3-fluoroglucose-independent utilization of lactate<br/>
510<br/>
L<br/>
<i>ptsHI</i><br/>
E, S<br/>
Fosfomycin resistance<br/>
146, 800<br/>
L<br/>
<i>ptsHI</i><br/>
E<br/>
Streptozotocin resistance<br/>
16, Freitag<i>h</i><br/>
L<br/>
<i>ptsI</i><br/>
E<br/>
Ampicillin resistance<br/>
212<br/>
<i>ptsI</i><br/>
S<br/>
Deoxy(3)-3-fluoroglucose resistance<br/>
510<br/>
L<br/>
<i>purA</i><br/>
E<br/>
Methyl(6)purine + hypoxanthine resistance<br/>
60<br/>
<i>purB</i><br/>
E<br/>
Nalidixic acid resistance<br/>
310<br/>
L<br/>
<i>purR</i><br/>
E<br/>
Adenine resistance in <i>hpt gpt</i><br/>
461, 462<br/>
<i>putA</i><br/>
E, S<br/>
Azetidine carboxylic acid resistance<br/>
511, 635, 775<br/>
L<br/>
<i>putAP</i><br/>
S<br/>
Baikiain resistance in constitutive background<br/>
187<br/>
L<br/>
<i>putA</i><br/>
S<br/>
Proline as N source with glucose as C source<br/>
566<br/>
<i>putP</i><br/>
E, S<br/>
Dehydroproline resistance<br/>
193, 511, 635, 732, 775, 843<br/>
L<br/>
<i>putP</i><br/>
E, S<br/>
Azetidine carboxylic acid resistance<br/>
193, 511, 635, 775, 843<br/>
L<br/>
<i>putP</i><br/>
S<br/>
Lithium-resistant proline utilization as C source<br/>
551<br/>
S<br/>
<i>puvA</i><br/>
E<br/>
Psoralen + UV irradiation resistance<br/>
328<br/>
C<br/>
<i>pyrB</i><br/>
S<br/>
Arginine-independent growth of <i>pyrH</i> in the presence of uracil<br/>
366<br/>
L<br/>
<i>pyrC</i><br/>
S<br/>
Arginine-independent growth of <i>pyrH</i> in the presence of uracil<br/>
366<br/>
L<br/>
<i>pyrD</i><br/>
S<br/>
Arginine-independent growth of <i>pyrH</i> in the presence of uracil<br/>
366<br/>
L<br/>
<i>pyrF</i><br/>
E<br/>
Fluoro(5)orotic acid resistance<br/>
74<br/>
L<br/>
<i>pyrH</i><br/>
S<br/>
Fluoro(5)orotic acid resistance<br/>
865<br/>
C<br/>
<i>pyrH</i><br/>
S<br/>
Fluorouracil resistance<br/>
385<br/>
C<br/>
<i>pyrH</i><br/>
S<br/>
Fluorouridine resistance<br/>
385<br/>
C<br/>
<i>pyrH</i><br/>
E<br/>
Fluoro(5)uracil + 5-fluorouridine resistance in <i>udp</i><br/>
606<br/>
<i>qmeACDE</i><br/>
E<br/>
Glycine tolerance<br/>
829<br/>
<i>rap</i><br/>
E<br/>
Lambda phage resistance<br/>
279<br/>
<i>recA</i><br/>
E<br/>
Lambda prophage induction deficiency during thymine deprivation<br/>
190<br/>
<i>recF</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
558<br/>
<i>recJ</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
558<br/>
<i>recO</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
558<br/>
<i>recQ</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
557<br/>
<i>relA</i><br/>
E<br/>
UV (near) irradiation resistance<br/>
632<br/>
L<br/>
<i>relA</i><br/>
E<br/>
Serine resistance in <i>relA</i><br/>
167<br/>
<i>rep</i><br/>
E<br/>
P2 phage resistance<br/>
113<br/>
<i>rfa</i> (general)<br/>
E, S<br/>
U3 and FO phage resistance<br/>
35, 484, 486, 588, 833<br/>
<i>rfa</i> (general)<br/>
E, S<br/>
Ampicillin resistance<br/>
212, 550, 562<br/>
<i>rfa</i> (general)<br/>
S<br/>
Hemin satisfaction of <i>hemA</i> auxotrophy<br/>
364<br/>
<i>rfa</i> (general)<br/>
S<br/>
Cephalothin resistance<br/>
562<br/>
<i>rfa</i> (general)<br/>
S<br/>
Bacitracin resistance<br/>
562<br/>
<i>rfaCDEF</i><br/>
S<br/>
FO phage resistance<br/>
676<br/>
<i>rfaD</i><br/>
E<br/>
C21 phage resistance<br/>
141<br/>
<i>rfaD</i><br/>
E<br/>
P1 phage resistance<br/>
141<br/>
<i>rfaH</i><br/>
S<br/>
FO phage resistance<br/>
458, 675<br/>
<i>rfaP</i><br/>
E<br/>
U3 phage + K3 phage coresistance<br/>
601<br/>
<i>rfb</i><br/>
S<br/>
DCCD resistance in <i>rfa</i><br/>
833<br/>
<i>rho</i><br/>
E<br/>
T4 phage resistance<br/>
740<br/>
<i>rho</i><br/>
E<br/>
Lambda <i>sus N7 nin-5</i> resistance in P2 lysogen<br/>
352, 353<br/>
<i>rho</i><br/>
E, S<br/>
Polarity suppression of <i>gal</i> leader insertion<br/>
169, 331<br/>
<i>ridA</i><br/>
E<br/>
Rifampin + kasugamycin dependence<br/>
162<br/>
<i>ridB</i><br/>
E<br/>
Rifampin dependence<br/>
160<br/>
<i>rplC</i><br/>
E<br/>
Tiamulin resistance<br/>
73<br/>
<i>rplD</i><br/>
E<br/>
Erythromycin resistance<br/>
725, 840<br/>
S<br/>
<i>rplE</i><br/>
E<br/>
Thiopeptin resistance<br/>
467<br/>
<i>rplF</i><br/>
E<br/>
Gentamicin resistance<br/>
101<br/>
S<br/>
<i>rplK</i><br/>
E<br/>
Kasugamycin resistance<br/>
159<br/>
<i>rplK</i><br/>
E<br/>
DAP starvation of ∆(<i>mal-asd</i>) in the presence of serine, methionine, and glycine<br/>
165<br/>
<i>rplN</i><br/>
E<br/>
Kasugamycin resistance<br/>
159<br/>
<i>rplN</i><br/>
E<br/>
Lincomycin resistance<br/>
343<br/>
<i>rplO</i><br/>
E<br/>
Lincomycin resistance<br/>
343<br/>
<i>rplV</i><br/>
E<br/>
Erythromycin resistance<br/>
840<br/>
<i>rpoA</i><br/>
E<br/>
P2 <i>vir1</i> phage resistance<br/>
754<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Lambda <i>c</i>II + rifampin coresistance<br/>
296<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Streptovaricin resistance<br/>
863<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Rifampin resistance<br/>
216, 359, 369<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Streptolydigin resistance<br/>
357, 469, 688<br/>
S<br/>
<i>rpoB</i><br/>
S<br/>
Fluorouracil resistance<br/>
368<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Lambda phage + 434 phage cross-resistance<br/>
256<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Lambda <i>Nmar </i>mutant phage resistance<br/>
261<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Serine resistance in <i>relA</i><br/>
784<br/>
S<br/>
<i>rpoB</i><br/>
E<br/>
Rifampin resistance in <i>rpoB</i>+/<i>rpoB</i> (<i>rif</i>) merodiploids<br/>
36<br/>
L<br/>
<i>rpoB</i><br/>
E<br/>
T7 phage resistance<br/>
690<br/>
S<br/>
<i>rpoC</i><br/>
E<br/>
T7 phage gene 2 resistance<br/>
100<br/>
<i>rpoD</i><br/>
E<br/>
Lambda <i>c</i>I71 resistance<br/>
556<br/>
<i>rpoD</i><br/>
E<br/>
Arabinose (L) as C source in <i>cya</i> or <i>crp</i><br/>
712<br/>
S<br/>
<i>rpoH</i><br/>
E<br/>
Temperature resistance in <i>rpoD</i>(Ts)<br/>
577<br/>
S<br/>
<i>rpsB</i><br/>
E<br/>
Kasugamycin resistance<br/>
583, 861<br/>
S<br/>
<i>rpsB</i><br/>
E<br/>
Cold resistance in <i>rpsE</i> cold-sensitive mutants<br/>
559<br/>
<i>rpsC</i><br/>
E<br/>
Spectinomycin resistance and sucrose dependence<br/>
195<br/>
S<br/>
<i>rpsD</i><br/>
E<br/>
Spectinomycin resistance and sucrose dependence<br/>
195<br/>
S<br/>
<i>rpsD</i><br/>
E<br/>
Streptomycin independence of streptomycin-dependent <i>rpsL</i><br/>
304<br/>
<i>rpsE</i><br/>
E<br/>
Spectinomycin resistance and sucrose dependence<br/>
195, 526<br/>
S<br/>
<i>rpsE</i><br/>
E, S<br/>
Spectinomycin resistance<br/>
172, 495, 634, 672, 853<br/>
S<br/>
<i>rpsE</i><br/>
E<br/>
Streptomycin independence of streptomycin-dependent <i>rpsL</i><br/>
304<br/>
<i>rpsG</i><br/>
E<br/>
Lincomycin resistance<br/>
343<br/>
S<br/>
<i>rpsI</i><br/>
E<br/>
Kasugamycin resistance and dependence<br/>
161, 163<br/>
S<br/>
<i>rpsJ</i><br/>
E<br/>
Lambda prophage induction, resistance to<br/>
170, 246<br/>
S<br/>
<i>rpsL</i><br/>
E, S<br/>
Streptomycin resistance<br/>
89, 495, 853<br/>
S<br/>
<i>rpsL</i><br/>
E<br/>
Neamine dependence<br/>
798<br/>
<i>rpsL</i><br/>
E<br/>
Paromomycin resistance or dependence<br/>
853<br/>
S<br/>
<i>rpsL</i><br/>
E<br/>
Phenyl galactoside resistance of <i>lacP lacI</i> (nonsense) <i>supE</i><br/>
747<br/>
<i>rpsM</i><br/>
E<br/>
Kasugamycin resistance<br/>
159<br/>
<i>rpsQ</i><br/>
E<br/>
Neamine resistance<br/>
76, 119<br/>
S<br/>
<i>rpsR</i><br/>
E<br/>
Kasugamycin resistance<br/>
159<br/>
<i>rrn</i><br/>
E<br/>
Erythromycin resistance<br/>
704<br/>
S<br/>
<i>rrn</i><br/>
E<br/>
Chloramphenicol resistance<br/>
704<br/>
S<br/>
<i>rrn</i><br/>
E<br/>
Spectinomycin resistance<br/>
704<br/>
S<br/>
<i>sbaA</i><br/>
E<br/>
Serine resistance<br/>
166<br/>
<i>sbmA</i><br/>
E<br/>
Microcin B17 resistance<br/>
446<br/>
<i>sdh</i><br/>
E<br/>
Succinate-independent growth in <i>lpd</i><br/>
154<br/>
<i>secA</i><br/>
E, S<br/>
Azide resistance<br/>
227, 232, 584, 808, 864<br/>
<i>secA</i><br/>
E<br/>
Phenethyl alcohol resistance<br/>
808, 864<br/>
<i>semA</i><br/>
E<br/>
Microcin E492 resistance<br/>
622<br/>
<i>serA</i><br/>
E<br/>
Serine hydroxamate resistance<br/>
774<br/>
FBI, S<br/>
<i>serS</i><br/>
E<br/>
Serine hydroxamate resistance<br/>
774<br/>
S<br/>
<i>sidCF</i><br/>
S<br/>
Albomycin resistance<br/>
87, 478, 479, 674<br/>
<i>sidK</i><br/>
S<br/>
Albomycin resistance<br/>
87, 478, 479, 674<br/>
<i>sidK</i><br/>
S<br/>
ES18 phage resistance<br/>
87, 478, 479, 674<br/>
<i>sloB</i><br/>
E<br/>
Nalidixic acid tolerance<br/>
473<br/>
<i>sloB</i><br/>
E<br/>
Amidinopenicillin tolerance<br/>
473<br/>
<i>sorAT</i><br/>
E<br/>
Sorbose (L) as C source in crosses with wild strains<br/>
844<br/>
<i>spcB</i><br/>
S<br/>
Spectinomycin resistance<br/>
853<br/>
<i>srlA</i><br/>
E<br/>
Sorbitol + xylitol resistance<br/>
639<br/>
L<br/>
<i>srlD</i><br/>
E<br/>
Fructose as C source in <i>ptsF</i> or <i>ptsM</i><br/>
378<br/>
<i>sspA</i><br/>
E<br/>
P1 phage resistance<br/>
835<br/>
L<br/>
<i>strB</i><br/>
S<br/>
Streptomycin resistance<br/>
273, 853<br/>
<i>strC</i><br/>
S<br/>
Streptomycin resistance<br/>
648<br/>
<i>strM</i><br/>
E<br/>
Streptomycin resistance<br/>
671<br/>
<i>strM</i><br/>
E<br/>
Phenyl galactoside resistance of <i>lacI</i>q <i>lacI</i>(nonsense) <i>lacP supL</i><br/>
748<br/>
<i>sulA</i><br/>
E<br/>
UV irradiation resistance in <i>lon</i><br/>
373<br/>
L<br/>
<i>sulA</i><br/>
E<br/>
Methyl methanesulfonate resistance in <i>lon</i><br/>
373<br/>
L<br/>
<i>sulA</i><br/>
E<br/>
Nitrofurantoin resistance in <i>lon</i><br/>
252<br/>
L<br/>
<i>tabC</i><br/>
E<br/>
T4 phage resistance<br/>
258<br/>
<i>tct</i><br/>
S<br/>
Fluorocitrate resistance<br/>
724<br/>
L<br/>
<i>tct</i><br/>
S<br/>
Trifluorocitrate resistance<br/>
723<br/>
L<br/>
<i>tct</i><br/>
S<br/>
2-Fluoro-L-erythrocitrate resistance<br/>
32<br/>
L<br/>
<i>tdk</i><br/>
E, S<br/>
Azidothymidine resistance<br/>
207<br/>
L<br/>
<i>tdk</i><br/>
S<br/>
Fluorodeoxyuridine + uracil resistance in <i>deoA</i><br/>
54<br/>
<i>tdk</i><br/>
E<br/>
Fluoro(5)deoxyuridine resistance<br/>
749<br/>
L<br/>
<i>tdk</i><br/>
E<br/>
Bromo(5)deoxyuridine + UV irradiation resistance<br/>
319, 348<br/>
L<br/>
<i>tet</i><br/>
E, S<br/>
Fusaric acid resistance<br/>
72, 487<br/>
L<br/>
<i>tet</i><br/>
S<br/>
Quinaldic acid resistance<br/>
72<br/>
L<br/>
<i>thdA</i><br/>
E<br/>
Dapsone resistance<br/>
383<br/>
<i>thi</i><br/>
E<br/>
Pyrithiamine resistance<br/>
399<br/>
C<br/>
<i>thrA</i><br/>
E, S<br/>
Thialysine resistance<br/>
365<br/>
S, FBI<br/>
<i>thrA</i><br/>
E<br/>
Serine resistance<br/>
294<br/>
S, FBI<br/>
<i>thrABC</i><br/>
E<br/>
Amino(2)-hydroxy(3)-pentoate resistance<br/>
847<br/>
D<br/>
<i>thrS</i><br/>
E<br/>
Borrelidin resistance<br/>
248, 276, 560, 596<br/>
S, Q<br/>
<i>thyA</i><br/>
E, S<br/>
Aminopterin resistance<br/>
66, 123, 325, 730<br/>
L<br/>
<i>thyA</i><br/>
E<br/>
Trimethoprim resistance<br/>
66, 730<br/>
L<br/>
<i>tinA</i> (<i>tlr</i>)<br/>
E, S<br/>
Thiolutin resistance<br/>
381, 382, 714<br/>
<i>tmk</i><br/>
E<br/>
Dideoxy(2′,3′)thymidine resistance<br/>
176<br/>
S<br/>
<i>tnaA</i><br/>
E<br/>
Tryptophan-supported growth at 13°C<br/>
568<br/>
C<br/>
<i>tna</i><br/>
E<br/>
Indole + methyl(5)tryptophan-supported, glucose-resistant growth in ∆<i>trp</i><br/>
862<br/>
<i>tol</i><br/>
E<br/>
Bacteriocin tolerance<br/>
85, 120, 173, 236<br/>
<i>tolQAB</i><br/>
E<br/>
Colicin E1 resistance<br/>
449<br/>
<i>tolQAB</i><br/>
E<br/>
TuIa phage resistance<br/>
449<br/>
<i>tolB</i><br/>
E<br/>
Colicin E resistance<br/>
19<br/>
L<br/>
<i>tolB</i><br/>
E<br/>
Azaleucine resistance<br/>
19<br/>
L<br/>
<i>tolC</i><br/>
E<br/>
Colicin E1 tolerance<br/>
536, 653<br/>
L<br/>
<i>tolD</i><br/>
E<br/>
Colicin E2 and E3 tolerance<br/>
210<br/>
<i>tolD</i><br/>
E<br/>
Ampicillin resistance<br/>
105, 210<br/>
<i>tolE</i><br/>
E<br/>
Colicin E2 and E3 tolerance<br/>
210, 211<br/>
<i>tolE</i><br/>
E<br/>
Ampicillin resistance<br/>
210, 211<br/>
<i>tolI</i><br/>
E<br/>
Colicin Ia and Ib tolerance<br/>
120<br/>
<i>tolJ</i><br/>
E<br/>
Colicin L, A, and S4 tolerance<br/>
173<br/>
<i>tolM</i><br/>
E<br/>
Colicin M tolerance<br/>
302<br/>
<i>tolQ</i><br/>
E<br/>
Colicin group A tolerance<br/>
84a, 750<br/>
<i>tolQ</i><br/>
E<br/>
Filamentous phage tolerance<br/>
84a, 750<br/>
<i>tolR</i><br/>
E<br/>
Colicin group A tolerance<br/>
84a, 750<br/>
<i>tolR</i><br/>
E<br/>
Filamentous phage tolerance<br/>
84a, 750, 751<br/>
<i>tolZ</i><br/>
E<br/>
Colicin E2, E3, D, 1a, and 1b tolerance<br/>
503<br/>
<i>tonB</i><br/>
S<br/>
ES18 phage resistance<br/>
149, 741<br/>
<i>tonB</i><br/>
E<br/>
T1 phage resistance<br/>
46<br/>
<i>tonB</i><br/>
E<br/>
φ80 phage resistance<br/>
46<br/>
<i>tonB</i><br/>
E<br/>
Colicin B resistance<br/>
46, 623<br/>
<i>tonB</i><br/>
E, S<br/>
Albomycin resistance<br/>
85, 505, 741<br/>
<i>tonB</i><br/>
E<br/>
Colicin M resistance<br/>
85, 523<br/>
<i>tonB</i><br/>
S<br/>
Bacteriocin 4-59 resistance<br/>
741<br/>
<i>tonB</i><br/>
E<br/>
Cephalosporin E-0702 resistance<br/>
815<br/>
<i>topA</i><br/>
S<br/>
Kanamycin resistance<br/>
202<br/>
<i>topA</i><br/>
S<br/>
Neomycin resistance<br/>
202<br/>
<i>topA</i><br/>
S<br/>
Streptomycin resistance<br/>
202<br/>
<i>tpp</i><br/>
E<br/>
Alafosfalin resistance<br/>
603<br/>
L<br/>
<i>tpp</i><br/>
E<br/>
Triornithine resistance in <i>opp</i><br/>
44<br/>
L<br/>
<i>tppA</i><br/>
S<br/>
Tripeptide (toxic) resistance<br/>
263<br/>
<i>tppB</i><br/>
S<br/>
Tripeptide (toxic) resistance<br/>
263<br/>
<i>trmE</i>?<br/>
E<br/>
Phenyl galactoside resistance of <i>lacl</i>q <i>lacI</i>(nonsense) <i>lacP supL</i><br/>
748<br/>
<i>trp</i> (generic)<br/>
E, S<br/>
Fluoro(6)tryptophan resistance<br/>
42, 318<br/>
C<br/>
<i>trp</i> (generic)<br/>
E, S<br/>
Methyl(5)tryptophan resistance<br/>
42, 318<br/>
C<br/>
<i>trpE</i><br/>
E, S<br/>
Methyl(5)tryptophan resistance<br/>
114, 539<br/>
S, FBI<br/>
<i>trpE</i><br/>
E<br/>
Methyl(3)anthranilate resistance<br/>
308<br/>
S, FBI<br/>
<i>trpR</i><br/>
E, S<br/>
Methyl(5)tryptophan resistance<br/>
42, 137, 523, 746<br/>
<i>trpR</i><br/>
E<br/>
Chuangxinmycin resistance<br/>
850<br/>
<i>trpS</i><br/>
E<br/>
Indolmycin resistance<br/>
75<br/>
D<br/>
<i>trxA</i><br/>
E<br/>
T7 phage resistance<br/>
498<br/>
L<br/>
<i>trzA</i><br/>
S<br/>
Triazole resistance<br/>
339<br/>
<i>tsx</i><br/>
E<br/>
T6 phage resistance<br/>
99, 299, 490, 492, 620<br/>
L, S<br/>
<i>tsx</i><br/>
E<br/>
Colicin K resistance<br/>
99, 299, 490, 492, 620<br/>
L, S<br/>
<i>tsx</i><br/>
E<br/>
Albicidin resistance<br/>
69<br/>
<i>tufAB</i><br/>
E<br/>
Kirromycin resistance<br/>
220, 356, 763, 795<br/>
<i>tufAB</i><br/>
E, S<br/>
Mocimycin resistance<br/>
335, 794<br/>
<i>tyn</i><br/>
S<br/>
Tyramine as N source<br/>
549<br/>
<i>tyrA</i><br/>
E, S<br/>
Fluorophenylalanine resistance<br/>
270, 729<br/>
C<br/>
<i>tyrA</i><br/>
E<br/>
Amino(4)phenylalanine resistance<br/>
504<br/>
C<br/>
<i>tyrR</i><br/>
E, S<br/>
Amino(4)phenylalanine resistance<br/>
95, 504, 811<br/>
<i>tyrR</i><br/>
E<br/>
Fluorotyrosine resistance<br/>
130<br/>
<i>tyrR</i><br/>
S<br/>
Fluoro(4)phenylalanine resistance<br/>
729<br/>
<i>tyrS</i><br/>
E<br/>
Fluorotyrosine resistance<br/>
662<br/>
S<br/>
<i>ubi</i> (generic)<br/>
E<br/>
Neomycin resistance<br/>
265<br/>
L<br/>
<i>ubiF</i><br/>
S<br/>
Fluoro(5)uracil + carbamylaspartate resistance<br/>
404, 866<br/>
L<br/>
<i>ubiF</i><br/>
E<br/>
Gentamicin resistance<br/>
542<br/>
<i>ubiF</i><br/>
E<br/>
Streptomycin resistance<br/>
542<br/>
<i>udhA</i><br/>
S<br/>
Fluoro(5)uridine resistance<br/>
834<br/>
L<br/>
<i>udk</i><br/>
E<br/>
Fluoro(5)uridine + uracil resistance<br/>
380<br/>
L<br/>
<i>udk</i><br/>
E<br/>
Fluoro(5)uridine resistance in <i>upp</i><br/>
565<br/>
L<br/>
<i>udp</i><br/>
E<br/>
Fluoro(5)uracil + adenosine resistance<br/>
606, 617<br/>
L<br/>
<i>ugpAB</i><br/>
E<br/>
Fluorohydroxyacetone phosphate resistance<br/>
515<br/>
L<br/>
<i>ugpAB</i><br/>
E<br/>
Dihydroxybutylphosphonate resistance in <i>glpT</i><br/>
691, 692<br/>
L<br/>
<i>ugpAB</i><br/>
E<br/>
Glycerol-3-phosphate as C source in <i>glpT</i><br/>
691<br/>
C<br/>
<i>uhpR</i><br/>
E<br/>
Glucosamine 6-phosphate as C source<br/>
191<br/>
C<br/>
<i>uhpR</i><br/>
S<br/>
Glucose 1-phosphate as C source<br/>
192<br/>
C<br/>
<i>uhpR</i><br/>
E<br/>
Fructose 1-phosphate as C source<br/>
224<br/>
C<br/>
<i>uhpT</i><br/>
E<br/>
Chloro-3-hydroxyacetone resistance in <i>uhp</i>(Con)<br/>
515<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Fluoro-3-hydroxyacetone resistance in <i>uhp</i>(Con)<br/>
515<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Dihydroxybutylphosphonate resistance in <i>uhp</i>(Con)<br/>
285<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Hydroxybutylphosphonate resistance in <i>ubp</i>(Con)<br/>
285<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Deoxydihydroxyphosphonyl methyl fructose resistance<br/>
285<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
L-Glyceraldehyde-3-phosphate resistance in <i>uhp</i>(Con)<br/>
285<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Fosfomycin resistance<br/>
230, 389, 800<br/>
L<br/>
<i>uhpT</i><br/>
E<br/>
Deoxy(2)glucose-6-phosphate resistance<br/>
214<br/>
L<br/>
<i>uidA</i><br/>
E<br/>
Galacturonide as C source<br/>
742<br/>
C<br/>
<i>uidA</i><br/>
E<br/>
Methylgalacturonide as C source<br/>
573<br/>
C<br/>
<i>uidA</i><br/>
E<br/>
Methylglucuronide + glycerol-supported growth in <i>eda</i><br/>
572<br/>
L<br/>
<i>uidR</i><br/>
E<br/>
Galacturonide as C source<br/>
742<br/>
C<br/>
<i>uidR</i><br/>
E<br/>
Methylgalacturonide as C source<br/>
573<br/>
C<br/>
<i>ung</i><br/>
E<br/>
Bromodeoxyuridine + UV light resistance<br/>
856<br/>
L<br/>
<i>ung</i><br/>
E<br/>
T4 phage (uracil containing) resistance<br/>
203<br/>
L<br/>
<i>upp</i><br/>
E, S<br/>
Fluoro(5)uracil resistance<br/>
53, 605, 617<br/>
L<br/>
<i>upp</i><br/>
E<br/>
Aza(6)uracil resistance<br/>
605, 617<br/>
L<br/>
<i>upp</i><br/>
E<br/>
Canavanine + aza(6)uracil resistance<br/>
605, 617<br/>
L<br/>
<i>ushA</i><br/>
E<br/>
Fluoro(5)uracil + 5′-AMP resistance in <i>upp</i><br/>
52<br/>
L<br/>
<i>uvrA</i><br/>
E<br/>
UV-irradiated lytic phage resistance<br/>
332<br/>
<i>uvrB</i><br/>
E<br/>
UV-irradiated lytic phage resistance<br/>
332<br/>
<i>uvrC</i><br/>
E<br/>
UV-irradiated lytic phage resistance<br/>
332<br/>
<i>uvrD</i><br/>
E<br/>
UV-irradiated lytic phage resistance<br/>
332<br/>
<i>uxaBC</i><br/>
E<br/>
Hexuronate resistance in <i>eda</i><br/>
742<br/>
L<br/>
<i>uxuAB</i><br/>
E<br/>
Hexuronate resistance in <i>eda</i><br/>
742<br/>
L<br/>
<i>uxuR</i><br/>
E<br/>
Methylgalacturonide as C source<br/>
574<br/>
C<br/>
<i>valS</i><br/>
E<br/>
Thymineless death resistance in <i>thyA</i><br/>
394<br/>
S<br/>
<i>xapA</i><br/>
E<br/>
Fluoro(5)uracil + adenosine resistance in <i>upp deoD xapR(Con)</i><br/>
111<br/>
L<br/>
<i>xapR</i><br/>
E<br/>
Adenosine as C source in <i>upp deoD</i><br/>
111<br/>
C<br/>
<i>xapR</i><br/>
E<br/>
Inosine as C source in <i>upp deoD</i><br/>
111<br/>
C<br/>
<i>xylE</i><br/>
E<br/>
Xylose resistance in <i>fda</i><br/>
175<br/>
L
